Introduction {#s1}
============

Cells of the same type growing in homogeneous conditions often have highly heterogeneous cycle lengths ([@bib43]). The minimal duration of the cell cycle will be determined by the maximal cellular growth rate in a given condition ([@bib22]). However, many cells, in particular, in multicellular organisms, do not grow at maximum rate, and their cycle length appears to be set by the progression of regulatory machinery through a series of checkpoints ([@bib34]). While much is known about the molecular mechanisms of cell-cycle regulation, we have little quantitative understanding of the mechanisms that control duration and variability of the cell cycle.

Recently, extensive live-cell imaging data of cell lineages have become available, characterizing, for example, lymphocyte activation ([@bib31]; [@bib13]; [@bib19]), stem cell dynamics ([@bib16]), cancer cell proliferation ([@bib44]; [@bib4]; [@bib38]), or nematode development ([@bib12]). Such studies across many cell types have found that cycle lengths are similar in sister cells, which may be due to the inheritance of molecular regulators across mitosis ([@bib44]; [@bib31]; [@bib51]; [@bib4]; [@bib3]). By contrast, ancestral correlations in cycle length fade rapidly, often disappearing between grandmother and granddaughter cells, or already between mother and daughter cells.

Remarkably, however, the cycle lengths of cousin cells are found to be correlated, indicating that the grandmothers exert concealed effects through at least two generations. High intra-generational correlations in the face of weak ancestral correlations have been observed in cells as diverse as bacteria ([@bib35]), cyanobacteria ([@bib50]), lymphocytes ([@bib27]) and mammalian cancer cells ([@bib45]; [@bib39]; [@bib8]). The ubiquity of this puzzling phenomenon suggests that it may help reveal basic principles that control cell-cycle duration.

Theoretical work has shown that more than one heritable factor is required to generate the observed cell-cycle correlations in T cell lineage trees, while the nature of these heritable factors has remained unclear ([@bib27]). Stimulated by the idea of circadian gating of the cell cycle in cyanobacteria ([@bib32]; [@bib50]), recent comprehensive analyses of cell lineage trees across different species have proposed circadian clock control as a source of cell-cycle variability that can produce the observed high intra-generational correlations ([@bib39]; [@bib33]; [@bib28]; [@bib36]); such a model also reproduced observed cycle correlations in colon cancer cells during chemotherapy ([@bib8]). However, in proliferating mammalian cells in culture, the circadian clock has been found to be entrained by the cell cycle ([@bib5]; [@bib15]). Moreover, the circadian clock is strongly damped or even abrogated by oncogenes such as MYC ([@bib2]; [@bib42]) yet MYC-driven cancer cells retain high intra-generational correlations ([@bib38]).

Ultimately, the cell cycle must coordinate growth and division in order to maintain a well-defined cell size over many generations. Yeast species have long served as model systems. Here, it is assumed that growth drives cell-cycle progression, although molecular mechanisms of size sensing remain controversial ([@bib14]; [@bib40]). By contrast, animal cells can grow very large without dividing ([@bib10]), and recent precise measurements suggest that growth control involves both modulation of growth rate and cell-cycle length ([@bib46]; [@bib47]; [@bib7]; [@bib18]; [@bib24]). A minimal requirement for maintaining cell size is that cells reach a critical size before dividing, which can be achieved by delaying S phase ([@bib41]).

Here, we present a systematic approach to learning mechanisms from measured correlation patterns of cell cycles in deep lineage trees. First, we develop an unbiased statistical framework to identify the minimal model capable of accounting for our experimental data. We then propose a biological realization of this abstract model based on growth, inheritance and a size checkpoint, and experimentally test specific predictions of the biological model.

Results {#s2}
=======

Lineage trees exhibit extended intra-generational correlations {#s2-1}
--------------------------------------------------------------

To study how far intra-generational cell-cycle correlations extend within cell pedigrees, we generated extensive lineage trees by imaging and tracking TET21N neuroblastoma cells for up to ten generations during exponential growth ([Figure 1A](#fig1){ref-type="fig"}, [Figure 1---video 1](#fig1video1){ref-type="video"}, [Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"} and [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). Autonomous cycling of these cells is controlled by ectopic expression of the *MYC*-family oncogene *MYCN*, overcoming the restriction point and thus mimicking the presence of mitogenic stimuli ([@bib38]). High *MYCN* also downregulated circadian clock genes ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). The distribution of cycle lengths ([Figure 1B](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}) was constant throughout the experiment ([Figure 1C](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"}) and similar across lineages ([Figure 1---figure supplement 1D](#fig1s1){ref-type="fig"}), showing absence of experimental drift and of strong founder cell effects, respectively. To determine cycle-length correlations without censoring bias caused by finite observation time ([Figure 1---figure supplement 3A](#fig1s3){ref-type="fig"}; [@bib39]), we truncated all trees after the last generation completed by the vast majority (\>95%) of lineages. The resulting trees were 5--7 generations deep, enabling us to reliably calculate Spearman rank correlations between relatives up to second cousins ([Figure 1D,E](#fig1){ref-type="fig"} and [Figure 1---figure supplement 3B](#fig1s3){ref-type="fig"}).

![Cell-cycle lengths and their correlations captured by live-cell imaging.\
(**A**) Live-cell microscopy of neuroblastoma TET21N cell lineages. Sample trees shown with cells marked that were lost from observation (dot) or died (cross). (**B**) Distribution of cycle lengths, showing median length (and interquartile range). (**C**) Cycle length over cell birth time shows no trend over the duration of the experiment. (**D**) Lineage tree showing the relation of cells with a reference cell (red); ancestral lineage (light blue), first side-branch (dark blue) and second side branch (green). (**E**) Spearman rank correlations of cycle lengths between relatives (with bootstrap 95%-confidence bounds) of three independent microscopy experiments. Color code as in D. B and C show replicate rep3.\
Figure 1---source data 1.Overview of all time-lapse experiments displayed in the manuscript.'Corrected' refers to the number of fully observed generations; only these were used, in order to correct for censoring bias. 'Figures' refers to main text figures and the respective supplements.\
Figure 1---source data 2.Raw cell cycle data for lineage trees in TET21N replicates rep1-3.](elife-51002-fig1){#fig1}

Cycle-length correlations of cells with their ancestors decreased rapidly with each generation ([Figure 1E](#fig1){ref-type="fig"}). However, the correlations increased again when moving down from ancestors along side-branches---from the grandmother toward the first cousins and also from the great-grandmother toward the second cousins ([Figure 1E](#fig1){ref-type="fig"}). The correlations among second cousins varied somewhat between replicates (we will show below that we can control these correlations experimentally by applying molecular perturbations). If cell-cycle length alone were inherited (e.g. by passing on regulators of the cell cycle to daughter cells), causing a correlation coefficient of $\rho_{md}$ between mother and daughter cycle lengths, and sisters are correlated by $\rho_{ss}$, then first and second cousins would be expected to have cycle length correlation $\rho_{ss}\rho_{md}^{2}$ and $\rho_{ss}\rho_{md}^{4}$, respectively ([@bib45]). The actually observed cousin correlations are much larger, confirming previous observations on first cousins as summarized in [@bib39] and extending them to second cousins. This discrepancy between simple theoretical expectation and experimental data was not due to spatial inhomogeneity or temporal drift in the data ([Figure 1](#fig1){ref-type="fig"}; [Figure 1---figure supplement 3C-E](#fig1s3){ref-type="fig"}). Thus, the lineage trees show long-ranging intra-generational correlations that cannot be explained by the inheritance of cell-cycle length.

Correlation patterns are explained by long-range memories of two antagonistic latent variables {#s2-2}
----------------------------------------------------------------------------------------------

We used these data to search for the minimal model of cell-cycle control that accounts for the observed correlation pattern of lineage trees (Materials and methods and Appendix 2). To be unbiased, we assumed that cycle length $\tau$ is controlled jointly by a yet unknown number $d$ of cellular quantities that are inherited from mother to daughter, $\mathbf{x} = (x_{1},\ldots,x_{d})^{\mathsf{T}}$, such that $\tau = {\tau{({\sum_{l = 1}^{d}{\alpha_{l}x_{l}}})}}$, with positive weights $\mathbf{\alpha}$. We take $\mathbf{x}$ to be a Gaussian latent variable and, generalizing previous work ([@bib11]), describe its inheritance by a generic model accounting for inter-generational inheritance as follows: In any given cell $i$, $\mathbf{x}^{i}$ is composed of an inherited component, determined by $\mathbf{x}$ in the mother, and a cell-intrinsic component that is uncorrelated with the mother. The inherited component is specified by an inheritance matrix $\mathbf{A}$, such that the mean of $\mathbf{x}^{i}$ conditioned on the mother's $\mathbf{x}$ is $\langle\mathbf{x}^{i}|\mathbf{x}\rangle = \mathbf{A}\mathbf{x}$ ([Figure 2A](#fig2){ref-type="fig"}). The cell-intrinsic component causes variations around this mean with covariance $\langle{(\mathbf{x}^{i} - \mathbf{A}\mathbf{x})(\mathbf{x}^{i} - \mathbf{A}\mathbf{x})^{\mathsf{T}}|\mathbf{x}}\rangle = \mathbf{I}$, where, with appropriate normalization of the latent variables, $\mathbf{I}$ is the unit matrix. Additional positive correlations in sister cells may arise due to inherited factors accumulated during, but not affecting, the mother's cycle ([@bib3]; [@bib4]; [@bib51]); additional negative correlations may result from partitioning noise ([@bib46]). These are captured by the cross-covariance between the intrinsic components in sister 1 and 2, $\langle{(\mathbf{x}^{1} - \mathbf{A}\mathbf{x})(\mathbf{x}^{2} - \mathbf{A}\mathbf{x})^{\mathsf{T}}|\mathbf{x}}\rangle = \gamma\mathbf{I}$. In total, $d{({d + 1})}$ parameters can be adjusted to fit the correlation pattern of the lineage trees: the components $a_{lm}$ of the inheritance matrix $\mathbf{A}$, the weights $\alpha_{l}$ and the sister correlation $\gamma$. Together, these inheritance rules specify bifurcating first-order autoregressive (BAR) models for multiple latent variables governing cell-cycle duration.

![Bifurcating autoregressive inheritance models.\
(**A**) Coupled inheritance of $d$ Gaussian latent variables $x_{l}$ and cell-intrinsic fluctuations generate cycle lengths. (**B**) Relative model evidences calculated for $d = {1,2}$, for the indicated inheritance matrices $\mathbf{A} = {\lbrack a_{lm}\rbrack}$ and sister coupling $\gamma$. Although Model VII is the most parsimonious for replicates rep2 and rep3 (blue and gray bars), only Model V with unidirectionally coupled inheritance explains all data well, including rep1 (bordeaux bars). Error bars from Monte-Carlo integration. (**C**) Model fits for rep1. Single-variable inheritance (Model II) and pure cross-inheritance (VII) fails to generate strong intra-generational correlations; uncoupled inheritance (III) fails to generate low ancestral correlations; Model V fits the data best. Rank correlations of the data shown with bootstrap 95%-confidence bounds (black bars). Model prediction bands (colored bars) were generated from the range of the parameter sets with likelihood higher than 15% of the best fit, corresponding to a Gaussian 95% credible region. (**D**) Model V, best-fit ancestral autocorrelation functions, for cycle lengths $\tau$ and latent variables. Long-range memory in the latent variables is anticorrelated and masked in observed cycle times.](elife-51002-fig2){#fig2}

To determine the most parsimonious BAR model supported by the experimental data, we employed a standard Bayesian model selection scheme. Selection is based on the Bayesian evidence, which rewards fit quality while naturally penalizing models of higher complexity (defined as being able to fit more diverse data sets; for details see Appendix 2, Evidence calculation). Specifically, we evaluated the likelihood of the measured lineage trees for a given BAR model, used it to compute the Bayesian evidence, and ranked BAR models accordingly ([Figure 2B](#fig2){ref-type="fig"}).

The simplest model that generated high intra-generational correlations was based on the independent inheritance of two latent variables (Model III; [Figure 2C](#fig2){ref-type="fig"}, cyan dots), whereas one-variable models failed to meet this criterion (Model II, [Figure 2C](#fig2){ref-type="fig"}, blue dots and Model I). However, Model III consistently overestimated ancestral correlations and hence its relative evidence was low (\<10% for all data sets). To allow additional degrees of freedom, we accounted for interactions of latent variables. The most general two-variable model with bidirectional interactions (Model VI), overfitted the experimental data and consequently had low evidence. The models best supported by the data had unidirectional coupling, such that $x_{2}$ in the mother negatively influenced $x_{1}$ inherited by the daughters, that is with $a_{12} < 0$ and $a_{21} = 0$ ([Figure 2B](#fig2){ref-type="fig"}, Models IV, V and VII). Among these, Model VII, with a single inheritance parameter $a_{12}$, is simplest, but was not compatible with experimental replicate rep1 as it could not generate second-cousin correlations ([Figure 2B](#fig2){ref-type="fig"},C). Both Models IV and V were compatible with all replicates; however, Model V with only one self-inheritance parameter for both variables ($a_{11} = a_{22} > 0)$ was preferred (Model V, [Figure 2B,C](#fig2){ref-type="fig"}, orange dots). Model V produced a remarkable inheritance pattern ([Figure 2D](#fig2){ref-type="fig"}): Individually, both latent variables had long-ranging memories, with ∼50% decay over 2--3 generations. However, the negative unidirectional coupling cross-correlated the variables negatively along an ancestral line, resulting in cycle-length correlations that essentially vanished after one generation. Nevertheless, strong intra-generational correlations were reproduced by the model due to long-range memories of latent variables together with positive sister-cell correlations ($\gamma > 0$). We conclude that the coexistence of rapidly decaying ancestral correlations and extended intra-generational correlations can be explained by the inheritance of two latent variables, one of which inhibits the other.

Cell size and speed of cell-cycle progression are antagonistic heritable variables {#s2-3}
----------------------------------------------------------------------------------

During symmetric cell division, both cell size and regulators of cell-cycle progression are passed on from the mother to the daughter cells ([@bib44]; [@bib51]; [@bib3]; [@bib4]). We now show that simple and generic inheritance rules for these two variables provide a physical realization for BAR Model V.

To divide, cells need to both grow to a minimum size ([@bib41]) and receive license to progress through the cell cycle from the regulatory machinery ([@bib34]). Indeed, growth and cell-cycle progression can be separately manipulated experimentally in mammalian cells ([@bib17]). In particular, cells continue to grow in size when regulatory license is withheld, for example in the absence of mitogens, and growth is not otherwise constrained, for example by mechanical force or growth inhibitors ([@bib17]; [@bib10]).

While growth and cell-cycle progression are separable and heritable processes, they also interact. At the very least, the length of the cell cycle needs to ensure that cells grow to a sufficient size for division. This interaction alone implies an effect of one inherited variable, cycle progression, on the other, cell growth, that anti-correlates subsequent cell cycles (as required by BAR model V): If a delayed regulatory license prolongs the mother's cell cycle, it will grow large. By size inheritance, its daughters will be large at birth, reach a size sufficient for division quickly and hence may have shorter cell cycles. Thus, despite inheritance of growth and cell-cycle regulators mothers and daughters may have very different cycle lengths due to this interaction.

Based on these ideas, we formulated a simple quantitative model of growth and cell-cycle progression on cell lineage trees. We introduced the variables 'cell size' $s$, measuring metabolic, enzymatic and structural resources accumulated during growth, and $p$, characterizing the progression of the cell-cycle regulatory machinery. Unlike the latent variables of the BAR model $x_{1}$ and $x_{2}$, their mechanistic counterparts $s$ and $p$, respectively, are governed by rules reflecting basic biological mechanisms ([Figure 3A](#fig3){ref-type="fig"}, Appendix 3). Size $s$ grows exponentially and is divided equally between the daughters upon division. We found that under some experimental conditions generating long cell cycles (downregulation of *MYCN*, see below), stable cell size distributions required feedback regulation of growth rate, as seen experimentally ([@bib46]; [@bib47]); we implemented this as a logistic limitation of growth rate at large sizes for these conditions. The progression variable $p$ determines the time taken for the regulatory machinery to complete the cell cycle, which is controlled by the balance of activators and inhibitors of cyclin-dependent kinases. These regulators are inherited across mitosis ([@bib44]; [@bib51]; [@bib3]; [@bib4]) and hence the value of $p$ is passed on to both daughter cells with some noise. Cells divide when they have exceeded a critical size, requiring time $\tau_{g}$, and the regulatory machinery has progressed through the cycle, which takes an approximately log-normally distributed time ([@bib38]; [@bib31]) modeled as $\tau_{p} = {\exp{(p)}}$. Hence the cycle length is $\tau = {\max{(\tau_{g},\tau_{p})}}$. Apart from requiring a minimum cell size for division, the growth-progression model does not implement a drive of the cell cycle by growth and thus allows cells to grow large during long cell cycles. By this mechanism, the cell size variable $s$ is influenced by cycle progression, analogous to the BAR variable $x_{1}$. By contrast, the progression variable $p$ is not influenced by cell size, analogous to the variable $x_{2}$ in the BAR model.

![The growth-progression model.\
(**A**) Scheme of the growth-progression model with heritable variables relating to cell size $s$ and cycle progression timing $p$. (**B**) Measured and simulated cell-cycle length distributions (upper). Model distribution resolved by the division-limiting process (lower). (**C**) Measured and modeled correlation pattern with Spearman rank correlation coefficient and bootstrap 95%-confidence bounds. (**D**) Proportion of simulated cells limited by growth or progression. (**E**) Correlation of simulated mother-daughter cycle lengths colored by their division limitation: both by $\tau_{g}$ (black), both by $\tau_{p}$ (green), mother $\tau_{p}$ -- daughter $\tau_{g}$ (magenta), mother $\tau_{g}$ -- daughter $\tau_{p}$ (cyan). Percentage of cells in each subgroup and their correlation coefficients are shown. (**F**) Correlation of simulated cousin-cousin cycle length colored by the limitation of the common grandmother: by $\tau_{g}$ (orange) or $\tau_{p}$ (blue). (**G**) Autocorrelations along ancestral line of cycle length $\tau$, growth time $\tau_{g}$ and the progression time $\tau_{p}$, and the cross-correlation $\tau_{p}\tau_{g}$.\
Figure 3---source data 1.Best-fit parameter values of the growth-progression model for all experiments shown, obtained from ABC-simulations.Cell size was assumed to increase exponentially except for MYCN-inhibited cells, which were modelled by a logistic growth process with a fixed normalised maximum cell size $s_{max}$ equal to 20 times the threshold division size. The bottom two rows show the parameters used for simulated perturbations of growth cycle progression, respectively.](elife-51002-fig3){#fig3}

We fitted this model to the measured lineage trees by Approximate Bayesian Computation ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"} and [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}). The parameterized model yielded a stationary cell size distribution ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}) and reproduced the cycle-length distribution ([Figure 3B](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}) as well as the ancestral and intra-generational correlations ([Figure 3C](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1D](#fig3s1){ref-type="fig"}). Thus, the dynamics of cell growth and cell-cycle progression, coupled only through a minimum-size requirement, account for the intricate cycle-length patterns in lineage trees.

To gain intuition on the inheritance patterns of cycle length, we first considered ancestral correlations, focusing on mother-daughter pairs. Individual cell cycles in the model are either growth-limited, that is division happens upon reaching the minimum size, or progression-limited, that is the cell grows beyond the minimum size until the cycle is completed ([Figure 3D](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1E](#fig3s1){ref-type="fig"}). If both mother and daughter are progression-limited (i.e., the threshold size is exceeded by both), their cycles are positively correlated ([Figure 3E](#fig3){ref-type="fig"}, green dots). As in this case size inheritance is inconsequential, this positive correlation is explained by the inheritance of the cell-cycle progression variable $p$ alone. By contrast, all mother-daughter pairs that involve at least one growth limitation show near-zero ([Figure 3E](#fig3){ref-type="fig"}, cyan dots) or negative correlations ([Figure 3E](#fig3){ref-type="fig"}, magenta and black dots). This pattern is explained by the anti-correlating effect that daughters of longer-lived and hence larger mother cells require on average shorter times to reach the size threshold. Next, we considered intra-generational correlations, focusing on first cousins ([Figure 3F](#fig3){ref-type="fig"}). While cousins are positively correlated overall, this correlation is carried specifically by cousins that descend from a grandmother with a progression-limited cell cycle ([Figure 3F](#fig3){ref-type="fig"}, blue dots), whereas cousins stemming from a growth-limited grandmother are hardly correlated ([Figure 3F](#fig3){ref-type="fig"}, orange dots). Since progression-limited cells can grow large, this observation indicates that cousin correlations are mediated by inheritance of excess size, as is confirmed by conditioning cousin correlations on grandmother size ([Figure 3---figure supplement 1F](#fig3s1){ref-type="fig"}). Size inheritance over several generations is also evident in the autocorrelation of the time required to grow to minimum size, $\tau_{g}$ ([Figure 3G](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1G](#fig3s1){ref-type="fig"}, black dots). The autocorrelation of the progression time $\tau_{p}$ is also positive (but less long-ranging; [Figure 3G](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1G](#fig3s1){ref-type="fig"}, green squares), while the negative interaction with growth is reflected in the negative cross-correlation ([Figure 3G](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1G](#fig3s1){ref-type="fig"}, red triangles). In sum, the long-range memories of cell-cycle progression and cell growth are masked by negative coupling of these processes, causing rapid decay of cell-cycle length correlations along ancestral lines ([Figure 3G](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1G](#fig3s1){ref-type="fig"}, orange triangles). These inheritance characteristics of the growth-progression model mirror those of BAR model V (see [Figure 2D](#fig2){ref-type="fig"}).

Effects of molecular perturbations on cell-cycle correlations are correctly predicted by the model {#s2-4}
--------------------------------------------------------------------------------------------------

If the growth-progression model captures the key determinants of the cell-cycle patterns in lineage trees, it should be experimentally testable by separately perturbing growth versus cell-cycle progression. We first derived model predictions for these experiments. Intuitively, if growth limitation were abolished by slowing cell-cycle progression, only progression would be inherited and therefore mother-daughter correlations of cycle time could no longer be masked. As a result, we expect intra-generational correlations to be reduced relative to ancestral correlations when inhibiting cycle progression; conversely, inhibiting growth (and thereby increasing growth limitation) should raise them. Indeed, using the model to simulate perturbation experiments ([Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}), we found that growth inhibition increased cousin correlations relative to mother-daughter correlations, whereas slowing cell-cycle progression decreased these correlations ([Figure 4A](#fig4){ref-type="fig"}).

![Targeted perturbation of growth and cell-cycle progression.\
(**A**) Predictions for changes in the ratio $\rho_{c}/\rho_{md}$ of cousin to mother-daughter correlations, when slowing growth or cycle progress compared to the best-fit parameters (control). $\rho_{c1} =$ first cousins, $\rho_{c2} =$ second cousins. (B--F) Experimental perturbations of cycle progress and growth by *MYCN* inhibition and rapamycin treatment, respectively. (**B**) Cell size distribution. Areal forward scatter measured experimentally by flow cytometry for control *high*-MYCN, *MYCN*-inhibited and rapamycin-treated (40 nM) TET21N neuroblastoma cells; shown are two biological replicates, indicated by solid and dashed lines, that were measured with the same FACS settings. (**C**) Measured and best-fit model cycle length distributions. Median and interquartile range are indicated. (**D**) Measured (black) and best-fit correlation pattern of *MYCN*-inhibited and rapamycin-treated cells with Spearman rank correlation coefficient and 95%-confidence bounds. (**E**) Measured cousin/mother daughter correlation ratios. (**F**) Proportion of simulated cells limited by growth or progression, using best-fit parameters for *MYCN* inhibition or rapamycin-treatment.\
Figure 4---source data 1.Raw cell cycle data for lineage trees in perturbed TET21N replicates -myc1-2 and rap1-2.](elife-51002-fig4){#fig4}

To test this prediction, we slowed cell-cycle progression experimentally by reducing MYCN, exploiting the doxycycline-tunable *MYCN* gene integrated in the TET21N cells. Cells grew to larger average size ([Figure 4B](#fig4){ref-type="fig"}, blue lines) over longer and more variable cell cycles ([Figure 4C](#fig4){ref-type="fig"}). These data show that lowering MYCN slowed cell-cycle progression while allowing considerable cell growth. Further consistent with this phenotype, expression of mTOR, a central regulator of metabolism and growth ([@bib17]), was not lowered ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}). In a separate experiment, we inhibited cell growth by applying the mTOR inhibitor rapamycin, which reduced cell size by a small but reproducible amount ([Figure 4B](#fig4){ref-type="fig"}, red lines). This treatment also lengthened the cell cycle slightly ([Figure 4C](#fig4){ref-type="fig"}) but without changing MYCN protein levels ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). Thus, lowering MYCN and inhibiting mTOR are orthogonal perturbations that act on cell-cycle progression and cell growth, respectively. As predicted by the growth-progression model, these perturbations resulted in markedly different cycle-length correlation patterns within lineage trees ([Figure 4D,E](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1C,D](#fig4s1){ref-type="fig"}): Lowering MYCN decreased intra-generational correlation and, in particular, removed second-cousin correlations. By contrast, rapamycin treatment strongly increased intra-generational correlations and caused ancestral correlations to decline only weakly. Collectively, these findings support the growth-progression model of cell-cycle regulation.

Cousin correlations reflect active cell-size checkpoint {#s2-5}
-------------------------------------------------------

We then asked whether the cycle-length correlation patterns experimentally observed in lineage trees contain information about the underlying regulation. To this end, we fitted the BAR and growth-progression models to MYCN and rapamycin perturbation data. We again obtained good agreement with the data ([Figure 4C,D](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1C--E,G--J](#fig4s1){ref-type="fig"}). *MYCN* knockdown cells grew larger; to obtain a stable cell-size distribution for the corresponding model fits, we implemented logistic regulation of growth rate at large cell sizes. When we applied, for comparison, this regulation to the control and rapamycin treatment data, the model fits ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}) were not noticeably affected compared to purely exponential growth. This result indicates that growth rate regulation affecting large cells, as found experimentally ([@bib18]), is compatible with long-range intra-generational correlations in cell-cycle length.

In terms of fit parameters of the model, *MYCN* inhibition caused considerable slowing of cycle progression and also a moderate decrease in growth rate ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}, parameters $\mu$ and $k$, respectively). As a result, the vast majority of cell cycles were progression-limited ([Figure 4F](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1F](#fig4s1){ref-type="fig"}). For the rapamycin-treated cells, we estimated growth rates that were lower than for the control experiments on average, as expected ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}, parameter $k$). Also, correlations in cell-cycle progression increased in mother-daughter and sister pairs (parameters $a$ and $\gamma$, respectively). This is consistent with rapamycin inhibiting mTOR and hence growth, but not affecting drivers of the cell cycle, ERK and PI3K ([@bib1]), since then lengthening of the cell cycle due to slower growth may allow prolonged degradation of cell-cycle inhibitors, which would increase inheritance of cell-cycle length ([@bib43]). Taken together, rapamycin treatment increased the fraction of growth-limited cell cycles ([Figure 4F](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1F](#fig4s1){ref-type="fig"}) and inheritance of cell-cycle progression speed, thus causing increased ancestral and intra-generational correlations.

We hypothesized that growth may be limiting primarily for rapidly proliferating cell types, even without specific growth inhibition. We analyzed time-lapse microscopy data of non-transformed mouse embryonic stem cells ([@bib16]) that proliferate much faster than the neuroblastoma cells ([Figure 5A](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}). Side-branch correlations of cycle length were again large ([Figure 5B](#fig5){ref-type="fig"} [Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}), as seen in the previous data except for the *MYCN*-inhibited cells. Interestingly, the strength of the intra-generational correlations was most similar to the much more slowly dividing rapamycin-treated cells (cf. [Figure 4D](#fig4){ref-type="fig"}). As before, the BAR model required two negatively coupled variables to account for these data ([Figure 5C](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1D,E](#fig5s1){ref-type="fig"}). Fitting the growth-progression model to the data ([Figure 5A,B](#fig5){ref-type="fig"}), we found that the majority (∼60%) of cell cycles were limited by growth ([Figure 5D](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}), indicating that cycle length of fast proliferating mammalian cells is, to a large extent, controlled by growth.

![Rapid cell cycle of embryonic stem cells are frequently growth-limited.\
(**A**) Cycle length distribution of data (black) and growth-progression model (purple). (**B**) Measured (black) and modeled (purple) correlation pattern using the growth-progression model. (**C**) Model evidences of the BAR model, version numbering as in [Figure 2B](#fig2){ref-type="fig"}. (**D**) Proportion of simulated cells limited by growth or progression. Data from [@bib16] reanalyzed for cell-cycle duration.](elife-51002-fig5){#fig5}

Discussion {#s3}
==========

Here, we showed that the seemingly paradoxical pattern of cell-cycle lengths in lineage trees, with rapidly decaying ancestral and long-range intra-generational correlations, can be accounted for by the inheritance of two types of quantities: resources accumulated during the cell cycle (cell 'size') and regulators governing the speed of cell-cycle progression. The fact that these are fundamental processes in dividing cells may help explain the ubiquity of the paradoxical cell-cycle pattern. Targeted experimental perturbations of cell growth and cell-cycle progression support our model.

As an alternative mechanism underlying the observed cell-cycle variability and cousin correlations, modulation of the cell cycle by the circadian clock has been suggested, with strongest experimental evidence to date for cyanobacteria ([@bib39]; [@bib33]; [@bib36]). Unlike cyanobacteria, proliferating mammalian cells show entrainment of the circadian clock to the cell cycle with periods well below 24 hr ([@bib5]; [@bib15]). Whether in this setting the circadian clock could still influence cell-cycle correlations remains to be studied.

Our proposed mechanism for cycle length correlations was motivated by Bayesian model selection. All data sets which displayed long-range correlation patterns (control replicate rep1 and rapamycin treatment of neuroblastoma cells as well as ESCs) selected a BAR model featuring long-range inheritance of two memory variables, which is masked in mother-daughter pairs by an anticorrelating interaction between them. The growth-progression model shares these essential features. Size inheritance is predicted to be particularly long-range by the fits of the growth-progression model to the experimental data. This memory emerges because growth does not force cell-cycle progression, allowing cells to grow large in progression-limited cycles and then pass on size over several generations. Such weak coupling between concurrent processes echoes recent work in *E. coli* on timing of cell division ([@bib30]) and on the existence of two parallel adder processes for replication and division ([@bib49]). Of note, the latter paper also utilizes a statistical framework for systematic model selection against experimentally observed correlation patterns akin to our approach.

Our findings raise the question of the mechanistic modes by which cells coordinate cell cycle and growth, which has been a long-standing problem; see [@bib41] for historical references and [@bib20] for a recent review. Recent work on this problem has shown the existence of negative feedback of cell size on growth rate ([@bib18]). We have found that our results remain robust when implementing a simple form of such a feedback (logistic dependence of growth rate on size) in the growth-progression model. Another recent study has shown that growth of many mammalian cells during the cell cycle adds a volume that only weakly increases with cell volume at birth (termed near-adder behavior, [@bib7]). This behavior appears to be caused by a combination of growth-rate regulation and cell-size effects on cell-cycle progression. We expect that factoring in the cell-cycle length correlations studied here will help uncover the mechanistic details of cell size regulation. Refining our model in this direction may also help capture yet more detail of the correlation structure, such as the apparent increasing trend from aunt to first cousins and greataunt to second cousins. Moreover, we envisage that our inference approach could be extended to include finely resolved data on cell-cycle phases ([@bib9]) as well as multiple cell fates via asymmetric division and differentiation ([@bib13]).

Materials and methods {#s4}
=====================

Experimental methods {#s4-1}
--------------------

*MYCN*-tunable mammalian neuroblastoma SH-EP TET21N (RRID:[CVCL_9812](https://scicrunch.org/resolver/CVCL_9812)) cells were cultured as in [@bib25]. These TET21N cells were obtained from Dr. Frank Westermann (German Cancer Research Center, DKFZ) whose lab generated this line. This cell line is regularly authenticated by an in-house DKFZ service using STR profiling. Mycoplasma contamination testing was negative. *MYCN* and mTOR were inhibited using 1 μg/ml doxycycline or 20--40 nM rapamycin (Calbiochem, 553210--100 UG), respectively. Cells were grown on ibidi μ-slides and phase contrast images (Nikon Ti-E) acquired every 6--15 min for up to 7 days under controlled growth conditions. The presented data consists of independent biological and technical replicates with n = 3 for untreated TET21N cells, n = 2 for *MYCN*-inhibited and rapamycin-treated cells. Cells were tracked in Fiji (version 1.48d) using the tracking plugin MTrackJ ([@bib29]). For flow cytometry, cells were stained with MYCN primary antibody (Santa Cruz Biotechnology, Cat\# sc-53993; RRID:[AB_831602](https://scicrunch.org/resolver/AB_831602)), secondary fluorescence-conjugated antibody goat anti-mouse Alexa Fluor 488 IgG (Life Technologies Cat\#A-11001; RRID:[AB_2534069](https://scicrunch.org/resolver/AB_2534069)) and measured on a Miltenyi VYB MACSQuant Analyser. See Appendix 1 for details.

Data analysis {#s4-2}
-------------

MATLAB (R2016b) was used for all data analyses. Correlations represent Spearman rank correlations or, for the BAR model, Pearson correlation coefficients between the Gaussian-transformed cycle times. The difference between these two methods was far smaller than the experimental error. Error bounds were estimated by bootstrap re-sampling on the level of lineage trees. Censoring bias was avoided by truncating lineage trees after the last generation completed by all lineages within the experiment (see e.g. [@bib39] and Appendix 1), truncating the trees to 7, 6 and 5 generations for the three *MYCN* amplified experiments. *MYCN*-inhibited and rapamycin-treated trees were five generations deep.

Bifurcating autoregressive (BAR) model {#s4-3}
--------------------------------------

We constructed BAR models of cell-cycle inheritance, as described in detail in Appendix 2. Briefly, the cell state is determined by a vector of Gaussian (latent) variables which are inherited from the mother to the daughter cells by a linear map plus a cell-intrinsic noise term, which is correlated between daughters. The model is thus a Gaussian latent-variable model, where inheritance takes the form of an autoregressive vector-AR(1) process defined on a lineage tree. The cycle time is then calculated by an data-derived (approximately exponential) function of a weighted sum of the cellular state. We calculated whole-lineage tree log-likelihood functions analytically and used them to evaluate Bayesian Evidences (Bayes factors) that quantify the relative support from the data for various model variants.

The growth-progression model {#s4-4}
----------------------------

Cell-cycle progression is modeled by a fluctuating, centered Gaussian heritable variable $q$, analogous to version II of the BAR model. Variables were scaled and shifted, $p = {{\sigma_{p}q} + \mu}$, yielding log-normal progression durations $\tau_{p} = {\exp{(p)}}$. Size accumulation was modeled by exponential growth or for *MYCN* inhibition logistic growth. The normalized critical cell size $s_{\text{th}}$ fluctuates slightly and independently in each cell as $s_{\text{th}} = {1 + \zeta}$ with $\zeta \sim {\mathcal{N}{(0,\sigma_{g}^{2})}}$. The growth-progression model was implemented in Matlab (R2016b), R (3.4.3) and OCaml (4.06) and 30 trees of 7 generations simulated, corresponding to the experimental dataset sizes. The simulation was repeated 100 times to generate confidence bounds. Parameters were fitted using Approximate Bayesian Computation independently for each dataset. See Appendix 3 for details.
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The following previously published dataset was used:

RylT2017RNA-Seq of SHEP TET21N cells upon Doxorubicin treatmentNCBI Gene Expression OmnibusGSE98274

Experimental methods {#s8}
====================

Cell culturing and treatment {#s8-1}
----------------------------

*MYCN*-tunable mammalian neuroblastoma SH-EP TET21N (TET21N, RRID: [CVCL_9812](https://scicrunch.org/resolver/CVCL_9812)) ([@bib25]) cells were cultured in RPMI 1640 medium supplemented with 10% fetal calf serum and 1% penicillin/streptomycin at 37°C 5% CO~2~ and 88% humidity. Versene was used for harvesting. TET21N cells were originally isolated from a female patient. Cell lines are authenticated by the German Cancer Research Center in house facility every half-year. *MYCN*-inhibited populations were established by incubating cells with 1 μg/ml doxycycline for 48--72 hr prior to further analysis. Growth-inhibited populations were generated by treating cells with the mTOR inhibitor rapamycin (Calbiochem, 553210--100 UG) at 20 nM or 40 nM rapamycin dissolved in DMSO. Cells were treated with rapamycin or the same concentration of DMSO for 72 hr prior to harvesting for flow cytometry or live-cell microscopy.

Live-cell microscopy {#s8-2}
--------------------

10^3^ cells were grown on 8-well ibidi μ-slides coated with collagen IV (Cat\# 80822) in RPMI 1640 medium and imaged every 6--15 min for up to 7 days under controlled growth conditions at 37°C, 5% CO~2~ and 80% humidity (Pecon incubator P). Growth media was changed every 2--3 days. Phase contrast images were acquired with an inverted widefield microscope (Nikon Ti-E) using an EMCCD camera (Andor iXON3 885) and a 10x (CFI Planfluor DL-10x, NA 0.3) or 20x lense (CFI Plan Apochromat DM 20x, NA 0.75). Cells were tracked in Fiji (version 1.48d) using the manual tracking plugin MTrackJ ([@bib29]). The presented imaging data consists of independent biological and technical replicates with n = 3 for untreated TET21N cells, n = 2 for *MYCN*-inhibited cells and n = 2 for rapamycin-treated cells.

Flow cytometry and antibody staining {#s8-3}
------------------------------------

10^6^ cells were fixed with 4% paraformaldehyde for 15 min at room temperature. Permeabilization was performed in 90% ice-cold methanol for at least 24 hr at −20°C. Cells were washed in staining buffer (1% BSA, 0.1% TritonX in PBS), and incubated with 0.5--1 μg per sample of MYCN primary antibody (Santa Cruz Biotechnology, Cat\# sc-53993; RRID:[AB_831602](https://scicrunch.org/resolver/AB_831602)) for 1 hr at room temperature. Cells were washed 3x with staining buffer and incubated with a secondary flouresence-conjugated antibody, goat anti-mouse Alexa Fluor 488 IgG (Life Technologies Cat\#A-11001; RRID:[AB_2534069](https://scicrunch.org/resolver/AB_2534069)), again for 1 hr at room temperature. Cells were washed 3x with staining buffer and DNA content staining was performed with FxCycle Violet Stain (Thermo Fischer Scientific). A Miltenyi VYB MACSQuant Analyser was used for measurements and data was analysed using FlowJo software.

Transcriptomics {#s8-4}
---------------

mTOR mRNA expression data in TET21N cells under control and *MYCN*-inhibited conditions was obtained from RNA-Seq measurements by [@bib38] deposited at GEO (GSE98274).

Data analysis {#s8-5}
-------------

MATLAB (R2016b) was used for all data analysis steps.

Correlation coefficients {#s8-6}
------------------------

Correlation patterns of lineage trees of data and the growth-progression model represent Spearman rank correlations. For the bifurcating autoregressive (BAR) model, Pearson correlation coefficients are calculated between the Gaussian-transformed cycle times. These are the same as Gaussian rank correlations between cycle times. In practice, the differences between Gaussian rank correlations and Spearman rank correlations were much smaller than experimental error bounds on either, so we did not differentiate between the measures. Confidence bounds on correlation coefficients were estimated by bootstrap resampling on the level of lineage trees; resampling on the level of individual pairs of related cells would neglect the correlations between cells of the same tree and thus underestimate variability. Trees that did not contain information on the cell pair under analysis were removed prior to bootstrapping. At each bootstrap repeat, family trees were randomly drawn with replacement up to the number of trees in the original dataset. From the resulting bootstrap sample all cell pairs were used to calculate the sample correlation coefficient. This process was repeated 10,000 times. From the resulting distribution of correlation coefficients the 95% quantiles were used as confidence bounds.

Exponential growth {#s8-7}
------------------

For each experiment, an exponential growth model of the form $N_{t} = {N_{0}{\exp{({kt})}}}$ was fitted to cell counts over time by performing a maximum likelihood estimation using the trust-region algorithm in MATLAB.

Cell-cycle length distribution over time {#s8-8}
----------------------------------------

At each time point, the moving-window median was calculated from all cells born within a window of 10 hr before or after this point.

Randomization {#s8-9}
-------------

All cells within a dataset were randomly paired with each other and correlation of the resulting sample calculated. This procedure was repeated 10,000 times. From the resulting distribution the mean and the 95% quantiles are given.

Censoring {#s8-10}
---------

Censoring bias resulting from a finite observation time can lead to an overrepresentation of faster cells. To demonstrate this effect, we generated trees using a toy model with independent normally distributed cycle lengths. The trees were truncated at various total observation times and Spearman rank correlation coefficients between all related cells within the observation time window were sampled. As [Figure 1---figure supplement 3A](#fig1s3){ref-type="fig"} shows, short observation times strongly distort the sampled mother-daughter and sibling correlations away from their true value 0. The same basic effect persists for more distant relationships and can be further enhanced if cycle lengths are inherited. This censoring bias can be avoided by truncating lineage trees not after a given observation time, but after the last generation completed by all lineages within the experiment, uniformly over all trees (see *e.g.* [@bib39]). In this way slower and faster-cycling lineages are represented equally. Because some cells were inevitably lost from the field of view by migration, and a small percentage of cells showed extremely slow cycles, such a strict cut-off was unfeasible in our experiments. We assumed that cell loss by migration is not correlated to cycle length, so migrating cells were not counted as missing from otherwise complete trees. Within the remaining tree, we then determined the last generation to be included in our analysis by the following procedure: We first counted the number of cells $n_{\text{alive}}{(G)}$ within each generation $G$ that were still alive at the end of the observation period. The last generation $G_{\text{last}}$ to be included was then determined as the maximum generation such that$${\frac{\sum_{G = 1}^{G_{\text{last}}}{n_{\text{alive}}{(G)}}}{\sum_{G = 1}^{\infty}{n_{\text{alive}}{(G)}}} \leq {5\%}}.$$

All further generations were removed from the dataset. This procedure truncated the trees to 7, 6 and 5 generations, respectively for the three replicate experiments using our *MYCN* amplified cell line. *MYCN*-inhibited and rapamycin-treated trees were 5 generations deep.

Spatial trend {#s8-11}
-------------

To assess potential spatial biases related to locally variable conditions, cells were divided into a 4 × 4 grid according to their position at division. The cycle length distribution of cells within each grid region (containing ≥ 5 cells) was compared to the distribution (1) within every other grid region and (2) of the whole dataset at a 5% significance level using a two-sided Kolmogorov-Smirnov test and correcting for multiple testing using the Benjamini-Hochberg procedure (using functions ks.test and p.adjust in R). Note also that because cells are motile they experience a range of local environments during their lifetime.

Bifurcating autoregressive model for cycle inheritance {#s9}
======================================================

Setup {#s9-1}
-----

In order to explore systematically which simple local inheritance schemes can generate the experimentally observed cycle length correlations, we study a class of Gaussian latent variable models of adjustable complexity. In the models, the cycle length $\tau$ of a cell is obtained from a standard normal variable $\ell$ by a nonlinear transformation $\tau = {g{(\ell)}}$. In our data, cell cycle lengths are roughly log-normally distributed, so $g$ is approximately a shifted exponential function. To simplify and make the model more robust to outliers, we determine $g$ empirically, such that its inverse $g^{- 1}$ transforms the cell cycle length into a standard normal variate. That is, we choose ${g{(\ell)}} = {c_{\text{ex}}^{- 1}{({c_{\text{gauss}}{(\ell)}})}}$ where $c_{\text{gauss}}$ is the cumulative distribution function (CDF) of a standard normal distribution, and $c_{\text{ex}}$ is the empirical CDF of the experimental data. This transformation discards all information about the shape and mean value of the cycle length distribution; the set of $\ell$ variables then purely reflect the strength of correlations between cell cycles. The (Pearson) moment correlation coefficients between the variables $\ell$ are identical to the so-called Gaussian rank correlation coefficients ([@bib6]) between the corresponding cycle lengths $\tau$, which are similarly robust to outliers as the more common Spearman rank correlation.

The Gaussian variable $\ell$ is used to model correlation by inheritance. $\ell$ is a weighted sum of $d$ latent, centered Gaussian variables $\mathbf{x} = (x_{1},\ldots,x_{m})^{\mathsf{T}}$ with positive weights $\mathbf{\alpha} = (\alpha_{1},\ldots\alpha_{m})^{\mathsf{T}}$, denoted as vectors $\mathbf{x}$ and $\mathbf{\alpha}$. That is, $\ell = \mathbf{\alpha}^{\mathsf{T}}\mathbf{x} = \sum\limits_{l}\alpha_{l}x_{l}$. Inheritance in the model occurs by passing on latent variables from mother to daughter cells. The basic model equation relation reads$$\mathbf{x}^{i} = \mathbf{A}\mathbf{x} + b\mathbf{\xi}^{i} + \overline{b}\mathbf{\xi}^{\overline{\imath}}.$$

Here, a superscript $i = {1,2}$ denotes a daughter cell, and absence of a superscript refers to the mother cell. The matrix $\mathbf{A}$ implements inheritance: The average of a daughter's latent variables, given the mother's is $\langle\mathbf{x}^{i}|\mathbf{x}\rangle = \mathbf{A}\mathbf{x}$. This linear coupling of latent variables through inheritance may take any form compatible with the basic stability requirement that its operator norm must satisfy ${\parallel \mathbf{A} \parallel} < 1$. Since both daughters inherit the same contribution from the mother, inheritance correlates the daughters' latent variables positively. Daughter cells are also subject to random fluctuations which we model by standard normal random vectors $\mathbf{\xi}^{i}$. These fluctuations are correlated due to the term $\overline{b}\mathbf{\xi}^{\overline{\imath}}$ in [Equation 2](#equ2){ref-type="disp-formula"}. Here $\overline{\imath}$ designates the sister cell of $i$, for example $\overline{2} = 1$. We parametrize these correlations via$${{b = {\cos{({\beta/2})}}},{{\overline{b} = {\sin{({\beta/2})}}},{\gamma \equiv {2b\overline{b}} = {{\sin{\beta\text{,\ where}}} - {\pi/2}} < \beta < {\pi/2}}}}.$$

The sister correlations conditioned on the mother latent variables then become$$\langle\mathbf{x}^{i}{\mathbf{x}^{\overline{\imath}}}^{\mathsf{T}}|\mathbf{x}\rangle = \gamma\mathbf{I};\quad\langle\mathbf{x}^{i}{\mathbf{x}^{i}}^{\mathsf{T}}|\mathbf{x}\rangle = \mathbf{I},$$where $\mathbf{I}$ is the $d$-dimensional unit matrix. Positive sister correlations $({\gamma > 0})$ may arise due to fluctuations that occur within the mother cell after its cycle duration has been fixed and are shared by the daughters. Negative correlations $({\gamma < 0})$ may arise due to partitioning noise upon inheritance. Note that latent variable fluctuations are correlated between sisters but uncorrelated between different latent variables. Effectively, our choice of parametrization partitions all fluctuating cell cycle-relevant processes within the daughter cells into $d$ Gaussian components that are maximally decorrelated, similar to a principal component decomposition.

Overall, [Equation 2](#equ2){ref-type="disp-formula"} defines an unbiased model with linear, local inheritance of latent variables, and an output that is a linear combination of latent variables. Its Gaussian form may be justified as the maximum-entropy distribution ([@bib21]) for this problem, since only covariance information is used as an experimental input at this stage. Our model is a first-order vector autoregressive process, defined on the lineage tree of cells; it is a latent-variable generalization of the bifurcating autoregressive model already considered by Staudte and coworkers ([@bib45]). We remark that in [@bib45] the dimensionality is $d = 1$, and therefore $\mathbf{\alpha}$ is unnecessary.

Stationary exponential growth {#s9-2}
-----------------------------

Combining [Equations 2 and 4](#equ2 equ4){ref-type="disp-formula"} by the law of total variance, the latent covariance satisfies$$\langle\mathbf{x}^{i}{\mathbf{x}^{i}}^{\mathsf{T}}\rangle = \mathbf{A}\langle\mathbf{x}\mathbf{x}^{\mathsf{T}}\rangle\mathbf{A}^{\mathsf{T}} + \mathbf{I}.$$

In stationary exponential growth, averaging over a single lineage forward in time, a stationary distribution with mean $0$ and covariance $\mathbf{C}_{\infty}$ is established. Then $\langle\mathbf{x}^{i}{\mathbf{x}^{i}}^{\mathsf{T}}\rangle = \langle\mathbf{x}\mathbf{x}^{\mathsf{T}}\rangle = \mathbf{C}_{\infty}$, and [Equation 5](#equ5){ref-type="disp-formula"} implies$$$$

We take this stationary distribution of latent variables as initial condition for root cells of lineage trees, assuming they come from an equilibrated growth phase. This assignment is not strictly correct because the stationary distribution along forward lineages is different from the distribution of all cells in an exponentially growing population at a given time ([@bib23]); however, the difference was small for our parameters when tested numerically (not shown).

Computation of the likelihood {#s9-3}
-----------------------------

We aim to compute the probability of generating a lineage tree with given cycle lengths within the model. We fix a minimum generation number and consider only trees in which essentially all branches reach this number, thus discarding overhanging cells on some branches, (see also [@bib39]). This is crucial since in experiments with finite duration, selection bias would otherwise be introduced ([@bib11]).

We begin by indexing cells in a tree by their pedigrees, which are the sequences of sister indices counting from the root cell, for example $I = {i_{1}i_{2}\ldots i_{k}}$ for a cell in generation $k$ and $Ii_{k + 1}$ for one of its daughters. Sorting these indices, we can then arrange all Gaussian-transformed cycle lengths in a tree into a single vector $\underline{\mathbf{\ell}}$. Since $\underline{\mathbf{\ell}}$ is Gaussian with mean $\underline{0}$, its log-probability takes on the simple quadratic form$$\mathcal{\wp}(\underline{\mathbf{\ell}}) = \mathcal{\wp}(\underline{\mathbf{\ell}}|\mathbf{A},\gamma,\mathbf{\alpha}) = - \frac{1}{2}\lbrack\log\det(2\pi{\underline{\mathbf{C}}}_{\ell}) + {\underline{\mathbf{\ell}}}^{\mathsf{T}}{\underline{\mathbf{C}}}_{\ell}^{- 1}\underline{\mathbf{\ell}}\rbrack.$$

To evaluate [Equation 7](#equ7){ref-type="disp-formula"}, we need to determine the joint covariance matrix ${\underset{¯}{\mathbf{C}}}_{\ell}$ of Gaussian cycle lengths over the given tree structure as a function of the parameters $\mathbf{A},\gamma,\mathbf{\alpha}$. We start by first deriving the joint covariance matrix $\underset{¯}{\mathbf{C}}$ of the latent variables $\underline{\mathbf{x}}$. This is a block matrix with $d \times d$ blocks $\mathbf{C}^{IJ}$ that correspond to pairs of cells in well-defined relationships, such as mother-daughter, cousin-cousin, etc. Since the lineage tree is sampled from stationary growth, $\mathbf{C}^{IJ}$ depends only on the relationship of $I$ and $J$, that is on their respective ancestral lines up to the latest common ancestor, and not on the history before. In particular, if $I = {Ji_{k + 1}\ldots}$ then cell $I$ is a descendant of cell $J$ and we write this as $I > J$; otherwise we write $I \ngtr J$. Note that $I \ngtr I$.

Splitting one cell pedigree as $I = {Ki}$, from [Equation 2](#equ2){ref-type="disp-formula"} we derive the relations$$\langle\mathbf{x}^{Ki}{\mathbf{x}^{J}}^{\mathsf{T}}\rangle = \langle(\mathbf{A}\mathbf{x}^{K} + b\mathbf{\xi}^{i} + \overline{b}\mathbf{\xi}^{\overline{\imath}}){\mathbf{x}^{J}}^{\mathsf{T}}\rangle = \left\{ \begin{matrix}
{\mathbf{A}\langle\mathbf{x}^{K}{\mathbf{x}^{J}}^{\mathsf{T}}\rangle} & {J \ngtr K} & {(i)} \\
{\mathbf{A}\langle\mathbf{x}^{K}{\mathbf{x}^{K}}^{\mathsf{T}}\rangle\mathbf{A}^{\mathsf{T}} + \gamma\mathbf{I}} & {J = K\overline{\imath}} & {(ii)} \\
\end{matrix} \right.$$

[Equation 8](#equ8){ref-type="disp-formula"} lets us compute $\mathbf{C}^{IJ}$ by a recursive procedure, as follows:

-   Consider the case $I > J$. If $I = {Ki}$, then $J \ngtr K$. Now use [Equation 8 (i)](#equ8){ref-type="disp-formula"} repeatedly ($k$ times), moving up the ancestral line, until arriving at the form $\mathbf{C}^{IJ} = \mathbf{A}^{k}\langle\mathbf{x}^{J}{\mathbf{x}^{J}}^{\mathsf{T}}\rangle = \mathbf{A}^{k}\mathbf{C}_{\infty}$.

-   In the case ${I = {Ki_{1}\ldots i_{k}}},{J = {Kj_{1}\ldots j_{k^{\prime}}}}$ with $j_{1} = {\overline{\imath}}_{1}$, no cell is a descendant of the other, and their last common ancestor is $K$. Use [Equation 8 (i)](#equ8){ref-type="disp-formula"} (or its transpose) on both branches repeatedly until the form $\mathbf{A}^{k - 1}\langle\mathbf{x}^{Ki_{1}}{\mathbf{x}^{K{\overline{\imath}}_{1}}}^{\mathsf{T}}\rangle{\mathbf{A}^{k^{\prime} - 1}}^{\mathsf{T}}$ is obtained. Then use [Equation 8 (ii)](#equ8){ref-type="disp-formula"} to get $$

These two cases cover all possible cell-cell relations, so that the procedure fully determines the joint latent covariance $\underset{¯}{\mathbf{C}}$ for a given tree structure, inheritance matrix $\mathbf{A}$ and sister correlation $\gamma$.

Finally, to obtain the covariance ${\underset{¯}{\mathbf{C}}}_{\ell}$ of the Gaussian cycle lengths $\ell$, we project onto $\mathbf{\alpha}$. The elements of ${\underset{¯}{\mathbf{C}}}_{\ell}$ result as$$C_{\ell}^{IJ} = \langle\ell^{I}\ell^{J}\rangle = \mathbf{\alpha}^{\mathsf{T}}\langle\mathbf{x}^{I}{\mathbf{x}^{J}}^{\mathsf{T}}\rangle\mathbf{\alpha} = \mathbf{\alpha}^{\mathsf{T}}\mathbf{C}^{IJ}\mathbf{\alpha}.$$

This completes the evaluation of the log-probability $\mathcal{P}$ ([Equation 7](#equ7){ref-type="disp-formula"}), which is also equal to the log-likelihood of the model, $\mathcal{\wp}(\underline{\mathbf{\ell}}) = \mathcal{L}(\mathbf{A},\gamma,\mathbf{\alpha})$. Accounting for the constraint ${\langle\ell^{2}\rangle} = 1$ which we impose to fix the arbitrary normalization of $\ell$, the full model has ${{d^{2} + 1 + d} - 1} = {d{({d + 1})}}$ adjustable parameters. This number can be reduced by restricting the inheritance matrix to a specific form, or by setting $\gamma = 0$, as was done for the model variants discussed in the main text.

As a corollary, the Gaussian rank correlation between cycle lengths of any pair of cells results as$$\rho_{\tau^{I}\tau^{J}}^{\text{gauss}} = \rho_{\ell^{I}\ell^{J}} = \frac{C_{\ell}^{IJ}}{C_{\ell}^{II}} = \frac{\mathbf{\alpha}^{\mathsf{T}}\mathbf{C}^{IJ}\mathbf{\alpha}}{\mathbf{\alpha}^{\mathsf{T}}\mathbf{C}_{\infty}\mathbf{\alpha}}.$$

In the one-dimensional special case $d = 1$, the projection on $\alpha$ becomes irrelevant and [Equation 10](#equ10){ref-type="disp-formula"} reduces to$$\rho_{\tau^{I}\tau^{J}}^{\text{gauss}} = \left\{ \begin{matrix}
a^{k} & {I > J\,{or}\, J > I} \\
{a^{k + k^{\prime}} + \gamma a^{k + k^{\prime} - 2}/c_{\infty} = a^{k + k^{\prime} - 2}\lbrack a^{2} + \gamma(1 - a^{2})\rbrack} & {I \ngtr J\,{and}\, J \ngtr I} \\
\end{matrix} \right.,$$where ${k,k^{\prime}} \geq 1$ the distances to the latest common ancestor as in the algorithm above, and $a \equiv \mathbf{A}$ is the $1 \times 1$ inheritance matrix. Some special cases of [Equation 11](#equ11){ref-type="disp-formula"} given already in [@bib11] are $\rho_{\text{ss}}^{\text{gauss}} = {\lbrack{a^{2} + {\gamma{({1 - a^{2}})}}}\rbrack}$ for sisters and $\rho_{c1}^{gauss} = a^{2}\rho_{ss}^{gauss} = {\rho_{md}^{gauss}}^{2}\rho_{ss}^{gauss}$ for first cousins. In other words, to compute the correlation between related cells, one multiplies mother-daughter correlations along the path connecting them, taking a shortcut via the daughters of the last common ancestor where one instead multiplies with the sister-sister correlation. Specializing further to $\gamma = 0$, [Equation 11](#equ11){ref-type="disp-formula"} reduces to the well-known relation $\rho_{\tau^{I}\tau^{J}}^{gauss} = {\rho_{md}^{gauss}}^{k + k^{\prime}}$ where $k + k^{\prime}$ is the number of cell divisions linking $I$ and $J$. As detailed in the main text, these one-dimensional special cases are insufficient to explain our data.

Evidence calculation {#s9-4}
--------------------

To compare different model versions' ability to explain but not overfit the data, we employed a standard Bayesian model selection scheme (see e.g. [@bib48]; [@bib26]). Within this framework, model selection is treated on the same grounds as parameter inference; the task is to assign to each one out of a set $\mathcal{M}$ of models its likelihood to have generated the data. One or several plausible models can then be selected on these grounds. Concretely, the scheme proceeds as follows. The probability of model $M$ to generate data $\underline{\mathbf{\ell}}$ is obtained by integrating over all parameter values $\pi_{M}$, which are distributed over a parameter space $\Pi_{M}$ with prior distribution $p{({\pi_{M}|M})}$:$$p(\underline{\mathbf{\ell}}|M) = \int_{\Pi_{M}}p(\underline{\mathbf{\ell}}|\pi_{M},M)p(\pi_{m}|M)d\pi_{M}.$$

Here, $p(\underline{\mathbf{\ell}}|\pi_{M},M) = \exp\lbrack\mathcal{\wp}(\underline{\mathbf{\ell}})\rbrack = \exp\lbrack\mathcal{L}(\pi_{M})\rbrack$ is equal to the likelihood function for model $M$, [Equation 7](#equ7){ref-type="disp-formula"}. Applying Bayes' rule, the probability that among $\mathcal{M}$, $M$ was the model that generated the data, is then$$p(M|\underline{\mathbf{\ell}}) = \frac{p(M)p(\underline{\mathbf{\ell}}|M)}{\sum\limits_{\mathcal{M}}p(M^{\prime})p(\underline{\mathbf{\ell}}|M^{\prime})}.$$

When models are equivalent a priori as we assume here, then both the prior belief in a model, $p{(M)}$, and the entire denominator in [Equation 13](#equ13){ref-type="disp-formula"} are unimportant constants. Then the so-called evidence or Bayes factor, obtained by calculating$$E(M) = \int_{\Pi_{M}}p(\underline{\mathbf{\ell}}|\pi_{M},M)\, d\pi_{M},$$is proportional to each model's probability of having generated the data, [Equation 13](#equ13){ref-type="disp-formula"}. We calculated $E{(M)}$ numerically by Monte-Carlo integration of [Equation 14](#equ14){ref-type="disp-formula"}; in the main text we show the evidences relative to Model V. Conventionally, an advantage in $E$ of a factor of 10 or more is considered strong support in favor of a model.

We briefly discuss some important features of model selection by evidence. In the asymptotic case of large samples (not applicable for the present data), the evidence $E$ is approximated by the well-known Bayes information criterion (BIC), which is an alternative to the popular Akaike information criterion (AIC). While AIC is constructed to select a model whose predictions are maximally similar to future repetitions of the same experiment, evidence and BIC select the model that is most likely to have generated the existing data. BIC and evidence, but not AIC, have a desirable consistency property: If the models $\mathcal{M}$ are recruited from a hierarchy of nested models which also contains the true model, then the simplest model in $\mathcal{M}$ comprising the true model is always favored for large enough samples ([@bib48]). This consistency is a manifestation of a general preference of the evidence for parsimonious models. To illustrate this point, following [@bib26], we expand the log evidence around the maximum a-posteriori estimate $\pi_{M}^{*}$, using Laplace's method:$${{{\log E}{(M)}} \simeq {{{\mathcal{L}{(\pi_{M}^{*})}} + {\log{\det\left( {2\pi H_{M*}^{- 1}} \right)}}} - {{\log{vol}}{(\Pi_{M})}}} \simeq {{\mathcal{L}{(\pi_{M}^{*})}} + {\sum\limits_{i = 1}^{d}{\log\frac{s^{i}}{S^{i}}}}}}.$$

Here, $H_{M*} = \left. \left( \frac{\partial^{2}\mathcal{L}}{\partial_{\pi_{M}^{i}}\partial_{\pi_{M}^{j}}} \right) \right|_{\pi_{M}^{*}}$ is the Hessian of the log-likelihood, and for simplicity we have assumed a flat parameter prior ${p{(\pi_{M})}} = {{1/{vol}}{(\Pi_{M})}}$. The ith eigenvalue $2\pi/s_{i}$ of $H_{M*}$ determines the width $s_{i}$ of the peak of the posterior distribution around $\pi_{M}^{*}$, along the ith principal axis. In the last equality, we have written the parameter space volume ${{vol}{(\Pi_{M})}} = {\prod_{i}S_{i}}$ as a product of parameter ranges $S_{i}$ along the principal axes. [Equation 15](#equ15){ref-type="disp-formula"} can be interpreted as follows: As more parameters are added to a model, the fit accuracy, measured by $\mathcal{L}{(\pi_{M}^{*})}$, generally improves. However, each new parameter $i^{\prime}$ incurs a penalty $\log(s_{i^{\prime}}/S_{i^{\prime}}) < 0$. The more the new parameter needs to be constrained by the data, the more the evidence is reduced. Thus the basic mechanism of parsimony in Bayesian model selection is this: Complex models are characterized by a large number of parameters with wide a priori allowed ranges and sensitive dependence on the data; in other words, they require the data to pick parameters from a large set of possibilities. Complex models are penalized and ranked as less likely. Indeed, such an overly flexible model can be fitted to diverse data, which we should expect to diminish the support that a particular set of data can give to it.

Numerical efficiency and implementation {#s9-5}
---------------------------------------

The evaluation of $\mathcal{L}$ ([Equation 7](#equ7){ref-type="disp-formula"}) requires a final numerical inversion of the recursively assembled covariance ${\underset{¯}{\mathbf{C}}}_{\ell}$ to obtain the stiffness matrix, which costs $O{(N^{3})}$ operations, where $N$ is the number of cells in the tree. To reduce this cost, it is possible to devise an equivalent recursive scheme in which the projected stiffness matrix, not the covariance matrix, is computed recursively, using efficient block-inverse formulæin each recursive step. The computational complexity can then be improved to $O{(N^{2})}$. A version of this alternative, equivalent scheme was implemented in the programming language OCaml and used to obtain the results presented in the main text.

The growth-progression model {#s10}
============================

Setup {#s10-1}
-----

The growth-progression model is based on the idea that the two cell-cycle controlling processes are cell-cycle progression and cell growth. The state variables of both processes, namely, the timing of the regulatory license to divide encoded by $p$, and cell size $s$, respectively, are inherited from mother to daughter. The two processes are coupled via inheritance as detailed in the following.

The cell-cycle progression process {#s10-2}
----------------------------------

Inheritance of the velocity of cell-cycle progression is modeled by a fluctuating, centered Gaussian variable $q$, passed on from mother to daughter, entirely analogous to version II of the BAR model (see there for additional explanation), according to$${q_{i} = {{aq} + {b\xi_{i}} + {\overline{b}\xi_{\overline{\imath}}}}},$$where subscript $i = {1,2}$ denotes a daughter cell, $\overline{\imath}$ its sister, and no subscript, the mother. $a$ with ${|a|} < 1$, implements inheritance. The intrinsic fluctuation strength and coupling is given by $b$ and $\overline{b}$; effectively, daughter cells are correlated for given mother by, ${{{\langle{q_{i}q_{\overline{\imath}}}|q\rangle} = \gamma};{{\langle q_{i}^{2}|q\rangle} = 1}},$ where $\gamma = {2b\overline{b}}$. From the centered $q$ variables, shifted and scaled Gaussian variables $p = {{\sigma_{p}q} + \mu}$ were generated, finally yielding log-normal regulation cycle durations $\tau_{p} = {\exp{(p)}}$. The duration $\tau_{p}$ is the time elapsed since the last division until regulatory license is given to divide again. Overall, the progression process has four adjustable parameters, $\mu$, $\sigma_{p}$, $a$ and $\gamma$.

The growth process {#s10-3}
------------------

The growth duration $\tau_{g}$ is defined as the time to grow from an initial size $s_{b}$ to the threshold size $s_{\text{th}}$. Size accumulation was modeled by exponential growth with the exponential growth rate$${\frac{ds}{dt} = {ks}}.$$

However, under *MYCN* inhibition, exponential growth was prone to generate unreasonably large cells. Here we instead modeled growth by the logistic growth process$$\frac{ds}{dt} = k\left( {1 - \frac{s}{s_{\text{max}}}} \right)s,$$where $k$ is the growth rate constant and $s_{\text{max}}$ the maximum cell size. We fixed $s_{\text{max}} = 20$, to match the approximate cell size at which the growth rate starts to decrease with observations ([@bib46]; [@bib47]). The two growth laws [Equations 17, 18](#equ17 equ18){ref-type="disp-formula"} yield$$\tau_{g} = k^{- 1}\log\left( \frac{s_{th}}{s_{b}} \right)$$and$$\tau_{g} = k^{- 1}\log\left\lbrack \frac{s_{\text{th}}(s_{b} - s_{\text{max}})}{s_{b}(s_{\text{th}} - s_{\text{max}})} \right\rbrack,$$respectively.

The normalized threshold cell size $s_{\text{th}}$ fluctuates slightly and independently in each cell as $s_{\text{th}} = {1 + \zeta}$ with $\zeta \sim {\mathcal{N}{(0,\sigma_{g}^{2})}}$. At division, the final mother cell size $s_{\text{div}}$ is halved, with each daughter receiving a new size at birth $s_{b} = {s_{\text{div}}/2}$. Effectively, for the subset of cell cycles that are limited by growth, this process corresponds to a sizer mechanism [@bib14]. The growth process has two adjustable parameters, $k$ and $\sigma_{g}$.

Coupling progression and growth {#s10-4}
-------------------------------

The two processes are coupled via a checkpoint which requires both to be completed before a cell has license to divide. The cell-cycle length is then determined as $\tau = {\max{(\tau_{p},\tau_{g})}}$. If division is stalled by insufficient cycle progression, $s$ continues to accumulate until cell division, so that the final cell size $s_{\text{div}} > s_{\text{th}}$. Thus, inheritance of the growth process is influenced by the cycle progression process. In contrast, the progression process is inherited in an autonomous fashion. This unidirectional inheritance structure recapitulates the unidirectional coupling between hidden processes found in the preferred BAR models IV and V.

Model simulation {#s10-5}
----------------

The growth-progression model was implemented in Matlab (R2016b), R (3.4.3) and OCaml (4.06) (with identical results but increasing execution speed) and lineage trees were simulated. For each tree, an initial cell was generated with birth size $s_{b} = {s_{\text{th}}/2}$ and $p = \mu$ and subsequently, an unbranched single lineage was simulated for 100 generations for equilibration. Its final cell was used as founder cell for the tree. For the data shown, 30 trees of 7 generations each were simulated, roughly corresponding to the dataset sizes obtained experimentally. The simulation was repeated 100 times to generate confidence bounds.

Parameter optimization {#s10-6}
----------------------

Parameters were fitted using Approximate Bayesian Computation independently for each dataset. In an adaptive procedure, (sometimes non-uniform) prior distributions of model parameters were first generated. For each parameter set, 500 trees were simulated at a depth of 7 generations. To compare data $D$ and simulations $\hat{D}$, we used a set $S$ of summary statistics composed of the nine correlation coefficients as shown in [Figure 3C](#fig3){ref-type="fig"}, and the mean and all quartiles of the distribution of cell-cycle durations. A squared-distance between data and simulation summary statistics was calculated as$$\rho^{2}\lbrack S(\hat{D}),S(D)\rbrack = \sum\limits_{i = 1}^{N}\left\lbrack \frac{S(D_{i}) - S(\hat{D_{i}})}{\sigma_{i}} \right\rbrack^{2},$$where $\sigma_{i}$ were calculated based on the data bootstrap confidence (95%) bounds. Samples of the approximate posterior probability distribution of parameter values (Figure 3--figure supplement 3A ) were then generated by accepting parameter sets with ${\rho^{2}{({S{(\hat{D})}},{S{(D)}})}} < \epsilon$, weighted by the inverse of the local prior density in parameter space. We used a tolerance $\epsilon = 2$ but results were not sensitive to the choice of $\epsilon$ within the range $1\ldots 4$. Prior parameter ranges were extended as far as necessary for accepted sets to converge. The final accepted ranges of each parameter was used as credible regions, and the medians of each parameter distribution from these samples were selected as best-fits for further analysis.
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**Acceptance summary:**

Kuchen et al. have developed a general model that can explain the high degree of intra-generational correlation in cell cycle times that have been observed in multiple systems. Based on insight provided by this general model, they show that these correlations can arise from a unidirectional coupling of cell size and cell-cycle speed by a minimal cell-size checkpoint, which they verify using perturbation experiments.

**Decision letter after peer review:**

Thank you for submitting your article \"Hidden long-range memories of growth and cycle speed correlate cell cycles in lineage trees\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Naama Barkai as the Senior and Reviewing Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

Kuchen et al. have developed an interesting and general model that can explain the high degree of intra-generational correlation in cell cycle times that have been observed in multiple systems. First, using Bayesian inference on their own time-lapse data, they find that a model of two unidirectionally coupled heritable components that affect cell-cycle time best explains their data. They go on to propose that these components can be cell size and cell-cycle speed, provided that growth and division are coupled via a minimum size checkpoint. They then verify this model through perturbation experiments.

Essential Revisions:

Please address all comments below.

In particular please pay a special attention to the following two points:

1\) The concerns over reproducibility between datasets,

2\) Provide much clearer explanation of the unbiased model-selection.

Reviewer \#1:

The paper studies division time correlations within neuroblastoma cells through time-lapse microscopy. Their approach uses unbiased statistical models to infer a minimal model that they claim recapitulates the experimentally observed correlations within populations of cells based on a set of heritable factors influencing interdivision times. The authors then study a model of division times based on growth to a threshold size and the inheritance of cell cycle progression factors that determine the rate of passage through the cell cycle. The authors claim that this second model recapitulates WT data in addition to matching the correlations observed in cells either grown with rapamycin (to limit cell growth) or cells with a reduced rate of passage through the cell cycle obtained by restricting the expression of the oncogene MYCN.

I found their unbiased statistical approach of particular interest since they considered a range of hierarchical models and used a metric for evaluating them which accounts for potential effects of overfitting with larger numbers of fitting parameters. However, to interpret this section with a critical eye requires more intuition for the metric of discrimination between these hierarchical models. In particular, Equation 12 which appears to address this should be referenced and discussed in the main text. With regards to the rest of the paper, the predictions of the authors when varying the limitations of either growth or cell cycle progression were unclear. This would be greatly aided by giving the reader intuition about what one would expect for either \"pure\" model (either a pure sizer for size control or cells which are completely limited by cell cycle progression).

Additionally, the following main comments should be addressed:

1\) How are the fitting parameters re-evaluated when inhibiting growth or cell cycle progression relative to the control case?

2\) Why do the authors switch to logistic growth during the MYCN growth? This is currently not even mentioned in the main text. It is concerning that in order to fit the MYCN growth case this fundamental assumption needed to be altered.

3\) Is the agreement between the model predictions and the observed division time correlations robust to variations in the cell size control strategies assumed? There is increasing evidence that many mammalian cells follow an \"adder\" model (see for example Cadart et al., 2018 which is incorrectly referred to in the paper as supporting a critical size), so testing the model for this size control strategy would be an important test of the proposed model.

4\) The choice of cell cycle timing as a feature of interest was not adequately justified. The results would be stronger if the authors can use data on correlations in cell size between relatives to test Model V and its predictions.

5\) The explanation of the results shown in Figure 4 does not provide clear intuition for why the correlations should be altered in the observed fashion. It would be helpful if the authors took more care when explaining this. For example: The authors show in Figure 3E that growth-limited cells have negative mother-daughter correlations in cell cycle timing. This being the case, why is it that the mother-daughter correlations in the presence of rapamycin (Figure 4D) are in fact larger than those correlations measured in the MYCN treated cells?

Reviewer \#2:

In the present manuscript, Kuchen and colleagues investigate how regulation of cell cycle progression and cell growth are coupled using analysis of extended cell lineages and mathematical modeling. Initially, they performed time-resolved live-cell microscopy of a MYCN -- over-expressing neuroblastoma line to generate cell lineage trees spanning 5-7 generations. As previously reported, they observed higher intra-generational than ancestral correlations, which has so far been attributed to coupling between cell cycle and circadian clock (Sandler et al., 2015, Chakrabarti et al., 2018). The authors now took an unbiased approached based on a Gaussian latent variables and propose a model where two unidirectionally coupled variables are inherited to daughter cells. They mechanistically implement these two variables as cell growth and cell-cycle progression and show that it is sufficient to couple both through a minimal-size checkpoint to account for the observed correlation patterns in lineage trees. This model is supported by experimental perturbations of cell growth (via mTOR inhibition) and cell cycle progression (decreasing MYCN levels) as well as by analysis of existing lineage data from rapidly cycling human ES cells.

The paper is well written and easy to follow. The authors present a very plausible alternative explanations for the non-intuitive correlation patterns in lineage trees and provide further evidence for a size checkpoint in mammalian cell cycle regulation. As the focus of the manuscript is on the use of abstracted mathematical models to explain a complex cellular phenotype (inheritance of cell cycle length), there is little mechanistic/molecular inside regarding the details of the observed phenomena (e.g. minimal cell size checkpoint). However, the provided experimental validation provides strong support for the presented hypothesis. As an experimentalist, I would have liked to see additional orthogonal perturbations to further strengthen the data, but believe that this would be beyond the scope of this study.

Main points:

1\) While the modelling results match the data within the estimated error bounds, the correlation patterns seem to be less pronounced. For example, the increased correlation to first cousins compared to aunts in Figure 3C (and Figure 3---figure supplement 1D) is hardly reproduced in the model. Similarly, the correlations to the removed side-branch seem to be about equal for all generations in the model, while the data indicates increased intra-generational correlations. It would be helpful if the authors comment on and explain such deviations or limitations of the model.

2\) As a main assumption of the authors is that MYCN over-expression disrupts the circadian clock which has been previously linked to the inheritance patterns of cell cycle length, they should validate this in the cell line used. This could be done for example by quantifying BMAL1 expression in the presence/absence of doxycycline (see Figure 4---figure supplement 1A.

Reviewer \#3:

Kuchen et al. have developed an interesting and general model that can explain the high degree of intra-generational correlation in cell cycle times that have been observed in multiple systems. First, using Bayesian inference on their own time-lapse data, they find that a model of two unidirectionally coupled heritable components that affect cell-cycle time best explains their data. They go on to propose that these components can be cell size and cell-cycle speed, provided that growth and division are coupled via a minimum size checkpoint. They then verify this model through perturbation experiments. Although the paper appears to be of general interest to *eLife* readers, there are several points that require clarification before publication.

1\) Representation of data. The authors present 3 repeats of the time-lapse microscopy for neuroblastoma TET21N cell lineages. (Figure 1E). For the Bayesian analysis (Figure 2) they only show the different models plotted against Repeat 1 in the main and supplemental figures (which appears to be the bottom dataset of Figure 1E -- it would be helpful if the different repeats were labelled in this figure). However, there appears to be significant differences between the 3 repeats shown in Figure 1E. Although it is difficult to see (in part because the horizontal line across each axis is at a different value of the Cross correlation coefficient -- how was this value selected?) it appears that in repeats 2 and 3 the level of correlation in distant side branches is much lower (around 0). This appears particularly worrying given the results of the Bayesian analysis for Model VII (Figure 2---figure supplement 1). Although this model results in no correlation past first cousins, it gives the best fit to data for repeat 2 and 3 (better in fact than model 5, Figure 2---figure supplement 1), and only fails to reproduce replicate 1. This suggests that for 2 out of 3 datasets a model that assumes no correlations past first cousins is being selected as the best model from the Bayesian analysis. The authors should address this issue, and show plots of the Bayesian analysis against all 3 repeats.

In the rest of the figures, which dataset chosen is not consistent. Although they do display a fit of their growth/progression model to repeat 1 and 2 in the Figure 3---figure supplement 1, they now chose repeat 3 to display in Figure 3 -- which appears to be the best fit to the model. In Figure 4, panel C shows cell-cycle lengths for repeat 3, but it is not clear which repeat(s) is/are used in the calculation of the correlation ratios. It would be helpful if the authors were consistent with their data selection in the main figures and supplements throughout the paper.

2\) Experimental evidence for cell size/cell cycle checkpoint model. The authors relate latent variables x~1~ and x~2~ to cell size and the cycling of cell cycle factors respectively. However, since these quantities are not dynamically tracked throughout cell growth, I have some questions about the authors\' interpretation and model. First, the model assumes the existence of a size threshold. If size does not affect cell cycle progression (another assumption), that suggests small-born cells are under a sizer-type control, whereas large-born cells (progression limited) are under a timer-type control. Such a model seems difficult to square with ongoing work in other organisms, which typically find adder-type (many single-cell microbes but also a number of mammalian cell lines, cf. Cadart et al., 2018) or sizer-type (e.g. fission yeast) control. Could the authors comment on how their model is biologically justified and how does it relate to alternative models of cell growth? Timer control is usually not considered because, on its own, it does not generate stable cell size. Indeed, in the appendix the authors note that, in the progression-limited regime, their model generates cells that are too large, so they implemented logistic, rather than exponential growth. In my understanding, this effectively implements a sizer again. What evidence do the authors have for these assumptions?

On the other hand, in subsection "Effects ofmolecular perturbations on cell-cycle correlations correctly predicted by the model" the authors claim that the growth of MYCN-inhibited cells is not affected. How did the authors verify this? If growth is logistic, as in the model, then growth rate is clearly affected beyond a certain size. Naively, I would also expect slower growth rates if growth is exponential and cell size is homeostatic. Additionally, the effects on cell size due to the addition of rapamycin appears weak (Figure 4B) -- Is it possible to quantify this difference, with an estimation of errors?
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Author response

> Reviewer \#1:
>
> \[...\]
>
> However, to interpret this section with a critical eye requires more intuition for the metric of discrimination between these hierarchical models. In particular, Equation 12 which appears to address this should be referenced and discussed in the main text.

The reviewer asks us to elaborate on model selection. We agree that this is a critical issue. In response, we have added in the main text a short intuitive explanation on Bayesian evidence used for model selection: "Selection is based on the Bayesian evidence, which rewards fit quality while naturally penalizing models of higher complexity (defined as being able to fit more diverse data sets; for details see Appendix 2, "Evidence calculation")." To underpin this, we have greatly expanded on the fundamentals of Bayesian evidence and how we calculated it in Appendix 2, section Evidence calculation. Particular emphasis is placed on an intuitive explanation of how the penalty for overfitting is built-in to Bayesian model selection. While rather intuitive, this detailed explanation requires some technical preliminaries and recapitulates prior work of others. We therefore present it in an Appendix. In addition to the book by MacKay previously cited, we now also cite a review by Wasserman, 2000, that gives a lucid methodological overview of this topic.

> With regards to the rest of the paper, the predictions of the authors when varying the limitations of either growth or cell cycle progression were unclear. This would be greatly aided by giving the reader intuition about what one would expect for either \"pure\" model (either a pure sizer for size control or cells which are completely limited by cell cycle progression).

The reviewer points out that developing intuition on how the growth-progression model functions would help understand the outcome of the perturbation experiments. We thank them for making us think further in this direction. We have now made several additions throughout the paper that build upon each other in giving an intuitive view on how cell growth and cell-cycle progression interact in our model to yield the observed correlation patterns of cell-cycle length. Before outlining this new material, we first remark that a pure "sizer" model of the type proposed here is a degenerate case that may obscure, rather than enlighten, what happens in our model. A pure sizer would simply cause exactly equal (no threshold noise) or slightly anticorrelated (with noise) cell-cycle lengths in mother and daughters and have no long-range memory whatsoever. Of note, even the very fast proliferating ESCs in our manuscript are not described by a pure sizer. More generally, a pure sizer is also an unrealistic scenario in the light of recent data (e.g., Cadart et al., 2018, showing near-adder, rather than sizer, behavior for many mammalian cell lines), and hence we chose not to discuss it, mainly to avoid confusion. In the new sections building intuition for the model behavior, we emphasize from the start how growth and cycle-progression interact in generating long-range cell-cycle correlations.

This intuitive explanation: "While growth and cell-cycle progression are separable and heritable processes, they also interact. \[...\] Thus, despite inheritance of growth and cell-cycle regulators mothers and daughters may have very different cycle lengths due to this interaction." This interaction is then the basis for both rapidly decaying ancestral (e.g., mother-daughter) and long-range intragenerational correlations in cell-cycle length. This is now explained in a new paragraph: "To gain intuition ..." The new paragraph makes use of Figure 3E (already present previously), showing that mother and daughter cell cycles become anticorrelated due to the above-described influence of cell-cycle progression on growth.

To clarify the origin of long-range intragenerational correlations further, we have now added a new Figure 3F (complemented by new Figure 3---figure supplement 1F) and a new explanation: "While cousins are positively correlated overall, this correlation is carried specifically by cousins that descend from a grandmother with a progression-limited cell cycle (Figure 3F, blue dots), whereas cousins stemming from a growth-limited grandmother are hardly correlated (Figure 3F, orange dots). Since progression-limited cells can grow large, this observation indicates that cousin correlations are mediated by inheritance of excess size, as is confirmed by conditioning cousin correlations on grandmother size..."

These findings show that both low mother-daughter correlations and high intragenerational (e.g., cousin) correlations are *emergent* phenomena of the interplay between growth and cell-cycle progression. This intuition is then further developed in an amended paragraph on the perturbation experiments. In that paragraph, we found it quite helpful to first discuss the limiting case of a pure "timer", i.e. pure progression-limited cycles, as this is actually approximated experimentally by MYCN inhibition. Hence we have taken up, at least in part, the above concrete recommendation by the reviewer.

> Additionally, the following main comments should be addressed:
>
> 1\) How are the fitting parameters re-evaluated when inhibiting growth or cell cycle progression relative to the control case?

This question relates to two points: (i) prediction of the effects of perturbations and (ii) application of the model to the experimental data from the perturbation experiments. First, for the prediction of perturbation effects (Figure 4A), we used the parameters for TET21N cells control conditions (replicate rep1). To simulate inhibition of cell growth, we lowered the growth rate *k* by 10%. To simulate inhibition of cell-cycle progression, we increased the average cycle length via increasing the mean log of the progression time μ by 7.5%. These details were inadvertently omitted from the Materials and methods for which we apologize; we have now added these. Moreover, for ease of reference, we have now added a table with the numerical values of the parameters used in all the simulations as the new Figure 3---figure supplement 2, which complements Figure 3---figure supplement 1A, graphically depicting these values and their confidence bounds.

Second, after performing the perturbation experiments for growth and cell-cycle progression (using rapamycin and doxocyclin-inducible downregulation of MYCN, respectively) we refitted the model to the experimental data, subjecting all model parameters to optimization. For inhibition of cell-cycle progression, we found that the only parameter that showed a consistent difference between these perturbation data and control replicates 1-3 was μ, which was larger, corresponding to a longer cell-cycle duration (see Figure 3---figure supplement 1A, -myc1 and -myc2). For inhibition of cell growth, several parameters changed in an informative manner. Consistent with the known rapamycin effect, the estimated growth rates were either at the lower end (rap2) or strongly decreased (rap1) by comparison with the values for the control experiments. At the same time, mother-daughter and sister cell-cycle length correlations (*a* and g, respectively) increased. Mechanistically, such a tendency would be caused, for instance, by larger depletion of cell-cycle inhibitors. This finding is consistent with the action of rapamycin, which inhibits mTOR and hence growth, but leaves ERK and PI3K activities unaffected, which drive cell-cycle progression (e.g., Adlung et al., 2017). Hence, slower growth would delay attainment of the size threshold and thereby allow longer phases of degradation of inhibitors such as p21, which in turn should increase mother-daughter and sister correlations (Spencer et al., 2013). We added these results and a brief discussion of their biological significance in subsection "Cousin correlations reflect active cell-size checkpoint", in connection with Figure 4.

> 2\) Why do the authors switch to logistic growth during the MYCN growth? This is currently not even mentioned in the main text. It is concerning that in order to fit the MYCN growth case this fundamental assumption needed to be altered.

The reviewer correctly observes that when modeling cells with low MYCN, which proliferate slowly, we implement a limitation of growth rate via logistic growth, whereas in all other cases, we do not. This was done in this manner because we aimed at the simplest possible version of the growth-progression model for each particular situation. For all cases but the slowly growing and large low-MYCN cells, we obtained well-bounded distributions of the "size" (or resource) variable with a constant accumulation rate, i.e. exponential growth. To achieve this for low-MYCN cells, we needed to implement negative regulation of accumulation of the size variable, by introducing a logistic dependence of accumulation rate on size. This regulation kicks in at high values of the size variable that are very rarely reached when cells proliferate more rapidly, i.e. in high-MYC cells. Hence some form of growth limitation will surely exist, but it is largely inconsequential for the more rapid cell cycles. We have also verified that including growth limitation has only minor effects on the model fit results in the control and growth-inhibited conditions. In detail, we have made the following changes in response to this point of the reviewer:

1\) We explain more clearly in the main text that logistic growth was used for low-MYCN cells (first when introducing the model and then again in connection with fits to perturbation experiments, Figure 4 C, D).

2\) We now show in addition that the incorporation of a logistic growth limitation does not significantly alter the best-fit parameters and the corresponding fitted cell-cycle correlations in lineage trees when cell cycles are faster, as in TET21N control conditions and under rapamycin treatment. These results are shown in the new Figure 4---figure supplement 2. Hence leaving out growth limitation for faster growing cells is a valid approximation here.

3\) We now give a more concrete perspective on the implications of our findings on inheritance of cell-cycle speed and cell size for cell-size regulation, (Discussion paragraph two), see also our response to point 3) below.

> 3\) Is the agreement between the model predictions and the observed division time correlations robust to variations in the cell size control strategies assumed? There is increasing evidence that many mammalian cells follow an \"adder\" model (see for example Cadart et al., 2018 which is incorrectly referred to in the paper as supporting a critical size), so testing the model for this size control strategy would be an important test of the proposed model.

The reviewer raises the important question of size control strategies used by cells and refers to one of the basic phenomenological models, the adder model (a similar question was posed by reviewer \#3, Point 2).

We thank the reviewer for pointing out the ambiguous referencing of Cadart et al., 2018, which we have now corrected and expanded as follows: "...shown that growth of many mammalian cells during the cell cycle adds a volume that only weakly increases with cell volume at birth (termed near-adder behavior". Cadart et al. show that different mammalian cells fall within a continuum, ranging from sizer over adder to timer behavior, when quantifying cell size gain within one cell cycle. Our manuscript focuses on inheritance mechanisms that explain correlation patterns between cycles of related cells. Interestingly, our findings touch upon size control strategies, but from a different angle than the phenomenological timer, adder and sizer models. Our growth-progression model in effect combines "timer" cycles, when cycle duration is controlled by cell-cycle progression, and "sizer" cycles, when cycle duration is controlled by growth. Overall, the mix leads to a pattern of mitotic size versus birth size that lies between a pure timer and a pure adder, a behavior that has been observed experimentally by Cadart et al. for mammalian cell lines ([Author response image 1](#respfig1){ref-type="fig"}). This finding indicates that our model is principally consistent with findings by Cadart et al., although it does not explicitly implement an adder mechanism. Indeed, adder and sizer are phenotypic descriptions of cell growth behavior that could be realized by different types of cellular mechanisms. Given that the mechanistic basis of the fundamental findings by Cadart et al. is not fully understood, we regard it as beyond the scope of the current manuscript to test various hypotheses with our model. We indicate now in closing the Discussion that this may be a fruitful direction for future work.

![Simulation of the growth-progression model (with best-fit parameters for control rep1).\
The linear regression of final cell size versus cell size at birth shows a slope between 1 (pure adder) and 2 (pure timer), falling in the range of experimental data measured for mammalian cell lines by Cadart et al., 2018.](elife-51002-resp-fig1){#respfig1}

> 4\) The choice of cell cycle timing as a feature of interest was not adequately justified. The results would be stronger if the authors can use data on correlations in cell size between relatives to test Model V and its predictions.

As explained in our response to Point 3, our main focus is on the mechanisms that determine cell-cycle timing.

> 5\) The explanation of the results shown in Figure 4 does not provide clear intuition for why the correlations should be altered in the observed fashion. It would be helpful if the authors took more care when explaining this. For example: The authors show in Figure 3E that growth-limited cells have negative mother-daughter correlations in cell cycle timing. This being the case, why is it that the mother-daughter correlations in the presence of rapamycin (Figure 4D) are in fact larger than those correlations measured in the MYCN treated cells?

We agree that an intuitive explanation of the observed changes in correlation patterns was lacking. To give such an intuition, we need to interrogate the predictions of our growth-progression model. We have tried to do so in several places. First, we have added a more extensive discussion of how the interplay of growth and progression produce mother-daughter and cousin-cousin correlation (in subsection "Cell size and speed of cell-cycle progression are antagonistic heritable variables", connected to Figure 3E and F). We then explain in more detail how the experimental perturbations changed the growth-progression parameters (beginning with "In terms of fit parameters..."). In particular, rapamycin slows the growth rate but also increases the strength of inheritance of the progression process, consistent with a picture where prolonged cycles also make e.g. dilution of cell-cycle inhibitors towards the end of the cycle more pronounced, as detailed in our response to the reviewer's point 1) above. Thus, while growth-limited cycles are more frequent in presence of rapamycin, growth inhibition appears to also increase the inheritance of cell cycle factors, and together these effects produce the strong correlations shown in Figure 4D, including a mother-daughter correlation that is in fact higher than in MYCN inhibited conditions. We have added a statement to this effect in subsection "Cousin correlations reflect active cell-size checkpoint".

> Reviewer \#2:
>
> \[...\]
>
> Main points:
>
> 1\) While the modelling results match the data within the estimated error bounds, the correlation patterns seem to be less pronounced. For example, the increased correlation to first cousins compared to aunts in Figure 3C (and Figure 3---figure supplement 1D) is hardly reproduced in the model. Similarly, the correlations to the removed side-branch seem to be about equal for all generations in the model, while the data indicates increased intra-generational correlations. It would be helpful if the authors comment on and explain such deviations or limitations of the model.

The reviewer points out potential differences in detail between correlation structures in the experimental data and in the model. We agree with this point. Both BAR model and growth progression models do not show an increase of correlations from aunts to cousins, although they do produce a moderate increase of correlation descending down the second side branch. As the reviewer also points out, the rather substantial measurement error bounds currently preclude us from going further in this direction. Even higher-precision data, or combination with other datasets (e.g., on detailed mechanisms of size regulation) may be necessary for further refining our models (for instance, resolving cell-cycle phases) in the future. We now indicate this in the Discussion.

> 2\) As a main assumption of the authors is that MYCN over-expression disrupts the circadian clock which has been previously linked to the inheritance patterns of cell cycle length, they should validate this in the cell line used. This could be done for example by quantifying BMAL1 expression in the presence/absence of doxycycline (see Figure 4---figure supplement 1A).

The reviewer asks for additional evidence that the circadian clock is downregulated by high MYCN levels. In response, we compared the RNA levels of circadian clock genes in TET21N cells with high MYCN expression to their counterparts with downregulated MYCN (based on RNA-seq data obtained previously by us, Ryl et al., 2017). This analysis shows significant downregulation of four out of nine clock genes studied (*PER1, PER3, CRY2, NR1D1* downregulated); the other five genes (*ARNTL, PER2, CRY1, CLOCK, NR1D2*) are not significantly changed. At least two of those latter genes appeared moderately downregulated (*PER2, CLOCK*, but this was not significant) while none appeared upregulated.

As MYC/MYCN is known to induce moderate changes in transcript levels to a large number of genes, we asked whether the entire gene module of the circadian clock was coherently regulated. Applying a standard gene-module approach (Robinson and Smyth, 2008), we compared the transcript level of the circadian clock module formed by the nine clock genes to the expression of randomly drawn modules with similar dispersion of transcript levels as the clock module. In this comparison, the clock module was strongly (and significantly) downregulated. We have added these new data as Figure 1---figure supplement 4 and refer to this figure in the main text.

In a line of work separate from this manuscript, we engineered a stable dual-reporter TET21N cell line for imaging cell cycle (using the Cdt1 degron from the FUCCI markers) and circadian clock (fluorescent protein expression driven by *NR1D1*). In the first set of experiments, we found 1:1 phase locking with periods around 18 hours. As an example, [Author response image 2](#respfig2){ref-type="fig"} shows fluorescence traces of three cells. While analysis of more cell traces will be needed, this behavior is very similar to the 1:1 phase locking of cell cycle and circadian clock reported previously for mammalian cell lines (Bieler et al., 2014; Feillet et al., 2014), except that the clock in TET21N cells appears to be much noisier. The observed behavior is different from circadian gating or modulation of the cell cycle in cyanobacteria, which involves the circadian clock as an external oscillatory forcing with 24 hour period.

![Sample traces of three TET21N cells with fluorescent reporters for the circadian clock (black lines) and the cell cycle (red lines).\
Dual reporter TET21N cells were grown and imaged as described in the manuscript.](elife-51002-resp-fig2){#respfig2}

> Reviewer \#3:
>
> Kuchen et al. have developed an interesting and general model that can explain the high degree of intra-generational correlation in cell cycle times that have been observed in multiple systems. First, using Bayesian inference on their own time-lapse data, they find that a model of two unidirectionally coupled heritable components that affect cell-cycle time best explains their data. They go on to propose that these components can be cell size and cell-cycle speed, provided that growth and division are coupled via a minimum size checkpoint. They then verify this model through perturbation experiments. Although the paper appears to be of general interest to eLife readers, there are several points that require clarification before publication.
>
> 1\) Representation of data. The authors present 3 repeats of the time-lapse microscopy for neuroblastoma TET21N cell lineages. (Figure 1E). For the Bayesian analysis (Figure 2) they only show the different models plotted against Repeat 1 in the main and supplemental figures (which appears to be the bottom dataset of Figure 1E -- it would be helpful if the different repeats were labelled in this figure). However, there appears to be significant differences between the 3 repeats shown in Figure 1E. Although it is difficult to see (in part because the horizontal line across each axis is at a different value of the Cross correlation coefficient -- how was this value selected?) it appears that in repeats 2 and 3 the level of correlation in distant side branches is much lower (around 0). This appears particularly worrying given the results of the Bayesian analysis for Model VII (Figure 2---figure supplement 1). Although this model results in no correlation past first cousins, it gives the best fit to data for repeat 2 and 3 (better in fact than model 5, Figure 2---figure supplement 1), and only fails to reproduce replicate 1. This suggests that for 2 out of 3 datasets a model that assumes no correlations past first cousins is being selected as the best model from the Bayesian analysis. The authors should address this issue, and show plots of the Bayesian analysis against all 3 repeats.

The reviewer begins by pointing out that experimental data are not optimally presented in the manuscript. In particular, there was an error in Figure 1E, where two of the x-axes were inadvertently drawn at the wrong y position. We apologize for this drawing error and have corrected it. We have also added replicate labels in this figure panel.

The reviewer then continues to point out that the three control repeats differ with respect to the extent of long-ranging intra-generational correlations and, indeed, the selection of BAR models yields different results for repeat 1 versus repeats 2 and 3. We agree that these are important points which were not fully discussed in the original manuscript.

We understood that this discussion arises largely due to the fact that the results on BAR model selection are split between main figure (Figure 2) and supplement (Figure 2---figure supplement 1). To rectify this problem, we have revised these figures as follows:

1\) In the revised Figure 2, the complete selection of BAR models is shown. In the accompanying revision of the main text, we now discuss in more detail that the extent of long-ranging correlation differs between the control replicates and that this fact impacts model selection. Specifically, long-ranging correlations favor Model V over Model VII. To illustrate this, we show BAR model fits (including Model VII) versus repeat 1 in the main figure.

2\) To further emphasize this point we have now added the fits of the different BAR models also for experimental repeats 2 and 3, as also requested by the reviewer. To not overload the main figure, these are now shown in Figure 2---figure supplement 1.

The key conclusion of our model selection is that the existence of long-range correlations selects BAR models that with two latent variables that show both self-inheritance and cross-inheritance, as exemplified by Model V. We exclude Model VII because it cannot account for the full data.

This conclusion is then corroborated subsequently in the manuscript by the rapamycin experiments with TET21N cells (Figure 4---figure supplement 1H) and by the ESC data (Figure 5---figure supplement 1D). where, again, Model VII is rejected due to long-range correlations. Note that in these special cases, Model IV (which is a more complex "version" of Model V) would be acceptable. Finally, the MYCN inhibited experiments are compatible and even prefer Model VII, due to the absence of long-range correlations (Figure 4---figure supplement 1G). Overall, only Model V can account acceptably for the full set of perturbed data, making it the only candidate for a model that describes a general mechanism. This selection results already when taking only the set of MYCN-high experiments rep1-3 into account.

We have corrected the mis-labeled caption of Figure 4---figure supplement 1. In the Discussion section we now added a sentence stating more precisely why the BAR Model V is favored overall, summarizing the above arguments.

> In the rest of the figures, which dataset chosen is not consistent. Although they do display a fit of their growth/progression model to repeat 1 and 2 in the Figure 3---figure supplement 1, they now chose repeat 3 to display in Figure 3 -- which appears to be the best fit to the model. In Figure 4, panel C shows cell-cycle lengths for repeat 3, but it is not clear which repeat(s) is/are used in the calculation of the correlation ratios. It would be helpful if the authors were consistent with their data selection in the main figures and supplements throughout the paper.

The reviewer points out that, in Figures 3 and 4, fits of the growth-progression model are shown for different experimental replicates while the fits to the remaining repeats are shown in the supplements to these figures. We agree that this may appear confusing and have now chosen in a consistent manner to show fits to replicate rep1 in the main figures -- Figure 2 for the BAR model, Figure 3 for the growth-progression model, and again as control in Figure 4C (perturbation experiments) -- while fits to repeats 2 and 3 are shown in the respective figure supplements. This reordering of figure panels does not influence the conclusions drawn (see above). Also, for the guidance of the reader, we added an overview of all time-lapse experiments used in the paper, as the new Figure 1---figure supplement 2.

> 2\) Experimental evidence for cell size/cell cycle checkpoint model. The authors relate latent variables x~1~ and χ2 to cell size and the cycling of cell cycle factors respectively. However, since these quantities are not dynamically tracked throughout cell growth, I have some questions about the authors\' interpretation and model. First, the model assumes the existence of a size threshold. If size does not affect cell cycle progression (another assumption), that suggests small-born cells are under a sizer-type control, whereas large-born cells (progression limited) are under a timer-type control. Such a model seems difficult to square with ongoing work in other organisms, which typically find adder-type (many single-cell microbes but also a number of mammalian cell lines, cf. Cadart et al., 2018) or sizer-type (e.g. fission yeast) control. Could the authors comment on how their model is biologically justified and how does it relate to alternative models of cell growth? Timer control is usually not considered because, on its own, it does not generate stable cell size.

The reviewer raises the important question of how our growth-progression model relates to recent experimental work on size control mechanisms in mammalian cells and fission yeast (a similar point was also raised by reviewer \#1, Point 3).

The reviewer correctly points out that our growth-progression model combines "timer" cycles, when cycle duration is controlled by cell-cycle progression, and "sizer" cycles, when cycle duration is controlled by growth. Overall, the mix leads to a pattern of mitotic size versus birth size that lies between a pure timer and a pure adder (see [Author response image 1](#respfig1){ref-type="fig"}). Indeed, Cadart et al. show that different mammalian cells fall within a continuum from timer to adder to sizer when quantifying cell size gain during the cycle. Hence, our specific model lies within this continuum, between timer and adder. It is important here to point out that timer, adder and sizer are phenomenological models that do not rely on actual molecular mechanisms of size control. It is conceivable that a specific molecular mechanism may generate something different from any such pure model. The fact that our growth-progression model (a phenomenological model that per se does not focus on size control) creates a pattern of cell size gain intermediate between pure timer and pure sizer is interesting in this respect. However, as the mechanistic basis of the fundamental findings by Cadart et al. is not fully understood, we feel it is beyond the scope of the current manuscript to address these questions. We indicate now in closing the Discussion that this may be a fruitful direction for future work.

> Indeed, in the appendix the authors note that, in the progression-limited regime, their model generates cells that are too large, so they implemented logistic, rather than exponential growth. In my understanding, this effectively implements a sizer again. What evidence do the authors have for these assumptions?
>
> On the other hand, in subsection "Effects ofmolecular perturbations on cell-cycle correlations correctly predicted by the model" the authors claim that the growth of MYCN-inhibited cells is not affected. How did the authors verify this? If growth is logistic, as in the model, then growth rate is clearly affected beyond a certain size. Naively, I would also expect slower growth rates if growth is exponential and cell size is homeostatic.

The assumption of a minimum-size threshold in the growth progression model is clearly a parsimonious assumption intended to keep the number of model parameters to a minimum. There is now conclusive work showing that cells do sense their size and can adjust their growth rate as a result (e.g. Ginzburg et al., 2018). Indeed, we used such a mechanism -- implemented as a logistic dependence of growth rate on size -- to avoid size divergence when the fraction of growth-limited cycles becomes very small and progression-limited cycles dominate (as in the case of *MYCN* knockdown). Thus the critical question arises whether this type of sizer regulation would work in general in the growth-progression model. We have now tested this and found that incorporation of a logistic growth limitation does not significantly alter our results on cell-cycle correlations in lineage trees when cell cycles are faster, as in TET21N control conditions. This shows that our conclusion remain robust when feedback control of growth rate by size is incorporated.

Importantly, growth rate regulation kicks in at high values of the size variable that are very rarely reached when cells proliferate more rapidly. Hence some form of growth limitation will surely exist, but it is largely inconsequential for the more rapid cell cycles. Hence leaving out growth limitation for faster growing cells is a valid approximation.

These new results are shown in the new Figure 4---figure supplement 2 and commented on in the Results as well as in the last paragraph of the Discussion.

> Additionally, the effects on cell size due to the addition of rapamycin appears weak (Figure 4B) -- Is it possible to quantify this difference, with an estimation of errors?

Precise cell size (mass or volume) measurement is technically hard (see e.g., Tzur et al. 2009; Ginzberg et al., 2018; Cadart et al., 2018) and is not in the focus of the current paper. We used, as a robust proxy, the forward scatter in the flow cytometer. This does not allow quantification of size changes. We fully agree with the reviewer that the size decrease upon rapamycin treatment is small (we used doses of rapamycin that had a growth-inhibitory effect but did not stall cell cycling altogether). In response to the point by the reviewer, we now show two biological replicates side-by-side in amended Figure 4B for each condition (control, rapamycin, MYCN inhibition). These data show that the small size decrease upon rapamycin treatment is completely reproducible.

[^1]: These authors contributed equally to this work.
